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Abstract 
 
The aim of this study was to assess the most relevant time scales of antibiotics concentration 
variations at the sewage treatment plant (STP) inlet and to create a model for the simulation of 
short-term concentration variations. 
During one year six antibiotics (ciprofloxacin, clindamycin, metronidazole, norfloxacin, ofloxacin, 
and trimethoprim) were being successfully and repeatedly measured at the inlet of the STP of 
Vidy in Lausanne. The campaigns were arranged that way that seasonal, daily and hourly mass 
flow rate variations of the antibiotics could be analysed. The measurement campaigns confirmed 
the occurrence of seasonal antibiotics variations. The hourly variations showed about the same 
order of magnitude as the seasonal ones. The day-to-day variations were in general found to be 
not as heavy as seasonal and hourly variations. 
A model simulating the antibiotics concentrations at the STP inlet on an hourly basis has been 
developed. It is applied for three antibiotics (ciprofloxacin, norfloxacin and trimethoprim) in the 
catchment area of the STP of Vidy in Lausanne. The modelled antibiotics concentrations have in 
some cases another order of magnitude compared to the measurements. This could be due to 
seasonal effects that cannot be adjusted by the calibration such as the antibiotics losses during 
sewer transit that are not known a priori. It could also be due to hypotheses made on the amount 
of consumed antibiotics. The modelled detailed hourly dynamics are limited in their validity 
because of the random noise due to the Monte Carlo modelling approach. Moreover, the 
uncertainties concerning the toilet use attitudes are limiting for these short-term dynamics. The 
view on the general modelled dynamic throughout the day reveals a first antibiotic peak in the 
morning between 07:00 and 10:00 and a second one in towards evening between 17:00 and 21:00 
which corresponds perfectly to the findings of the measurement analysis. 
The development of the model allowed identifying the most important parameters contributing to 
short-term antibiotics dynamics namely the amount of consumed antibiotic and the number of 
persons administering the medicine, the behaviour of the antibiotics’ accumulation in the urine 
and the toilet use habits. 
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Résumé 
 
L’objective de ce projet était d’évaluer les échelles de temps les plus importantes des variations de 
concentrations d’antibiotiques à l’entrée de la station d’épuration des eaux usées (STEP) et de créer 
un modèle pour la simulation des variations de concentrations à court-terme. 
Pendant une année, six antibiotiques (ciprofloxacine, clindamycine, métronidazole, norfloxacine, 
ofloxacine et triméthoprime) ont été mesurés à succès et de façon répétée à l’entrée de la STEP de 
Vidy à Lausanne. Les campagnes de mesures ont été faites de manière à ce que les variations du 
flux de masse des antibiotiques puissent être analysées aux échelles saisonnières, journalières et 
d’heure en heure. La présence des variations saisonnières des antibiotiques a été confirmée. Les 
variations durant la journée ont montrées avoir unefréquence du même ordre de grandeur que les 
variations saisonnières. Les variations d’une journée à l’autre ont généralement été obsérvées d’être 
moins importantes que les variations saisonnières ainsi que celles d’heure en heure. 
Un modèle qui simule les concentrations d’antibiotiques à la résolution d’une heure a été 
développé. Il est appliqué pour trois substances (ciprofloxacine, norfloxacine et triméthoprime) 
dans le réseau d’assainissement de la STEP de Vidy à Lausanne. Dans certains cas les 
concentrations d’antibiotiques modélisées ont des différents ordres de grandeur par rapport aux 
mesures. Cela pourrait être dû à des effets saisonniers non ajustés par la calibration comme des 
pertes d’antibiotiques pendant leur passage à la STEP qui ne sont pas connues a priori. En outre 
cela pourrait être dû à des hypothèses faites sur la masse d’antibiotiques consommée. Les 
dynamiques détaillées d’une heure à l’autre générées par le modèle sont limitées dans leur force 
d’expression en raison du bruit du caractère fortuit de l’approche Monte Carlo du modèle. De plus, 
les incertitudes concernant les attitudes d’utilisation des toilettes limitent ces dynamiques à court-
terme. La vue sur la dynamique modélisée en général pendant la journée montre un premier pic 
d’antibiotiques le matin entre 7 heures et 10 heures et un deuxième le soir entre 17 heures et 21 
heures. Cela correspond exactement aux résultats de l’analyse des mesures. 
Le développement du modèle a permis d’identifier les paramètres contribuant le plus aux 
dynamiques des antibiotiques à court-terme. Ceux-ci sont la masse d’antibiotiques consommés et 
le nombre de personnes qui en ingèrent, le comportement de l’accumulation des antibiotiques 
dans l’urine et les habitudes d’utilisation des toilettes. 
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Zusammenfassung 
 
Das Ziel dieser Arbeit war es Schwankungen von Antibiotikakonzentrationen im Zufluss der 
Abwasserreinigungsanlage (ARA) auf deren bedeutendsten Zeiträume zu evaluieren sowie ein 
Modell zu schaffen, das kurzfristige Konzentrationsschwankungen simuliert. 
Während eines Jahres wurden sechs Antibiotika (Ciprofloxacin, Clindamycin, Metronidazol, 
Norfloxacin, Ofloxacin und Trimethoprim) wiederholt und erfolgreich im Zufluss zur ARA von 
Vidy in Lausanne gemessen. Die Messkampagnen waren so angeordnet, dass der 
Antibiotikamassenfluss auf saisonale, tägliche und stündliche Schwankungen analysiert werden 
konnte. Die Messkampagnen bestätigten das Auftreten von saisonalen Antibiotikaschwankungen. 
Die stündlichen Schwankungen zeigten sich in ungefähr denselben Grössenordnungen wie die 
saisonalen Schwankungen. Die Schwankungen der Tagesmittel von einem Tag zum nächsten, 
wurden im Allgemeinen als nicht so bedeutend befunden wie die saisonalen und stündlichen 
Konzentrationsschwankungen. 
Es wurde ein Modell entwickelt, das mit stündlicher Auflösung Antibiotikakonzentrationen im 
ARA-Zufluss simuliert. Das Modell wurde auf drei Antibiotika (Ciprofloxacin, Norfloxacin und 
Trimethoprim) im Einzugsgebiet der ARA von Vidy in Lausanne angewendet. Die simulierte 
Antibiotikakonzentrationen haben verglichen mit den gemessenen teilweise andere 
Grössenordnungen. Dies könnte mit saisonalen Effekten zu tun haben, die in der Kalibration nicht 
ausgeglichen werden können wie zum Beispiel mögliche Antibiotikaverluste während des 
Transportes durch die Kanalisation. Es könnte aber auch wegen Annahmen zur konsumierten 
Antibiotikamenge sein. Die simulierte stündliche Dynamik hat im Detail etwas beschränkte 
Aussagekraft wegen des Zufallsrauschens des Monte Carlo Modellansatzes. Zudem sind auch 
Unsicherheiten rund um die Verhaltensweisen der Toilettenbenützung limitierend für diese 
kurzfristigen Dynamiken. Die Ansicht der simulierten Tagesdynamik im Allgemeinen bringt 
zwischen 7 Uhr und 10 Uhr einen ersten Spitzenwert der Antibiotikakonzentration hervor und 
einen zweiten zwischen 17 Uhr und 21 Uhr. Dies entspricht genau den Befunden der Analyse der 
Antibiotikamessungen. 
Das Entwickeln des Modells erlaubte die wichtigsten Parameter zu erkennen, die zu den 
beachtlichen kurzzeitlichen Dynamiken beitragen. Dies sind nämlich die konsumierte 
Antibiotikamenge sowie die Anzahl der Konsumentinnen und Konsumenten, das 
Akkumulationsverhalten der Antibiotika im Urin und die Gewohnheiten der WC-Benützung. 
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Abbreviations 
 
ARA  Abwasserreinigungsanlage 
CSO  Combined sewer overflow 
LOD  Limit of detection 
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1 Introduction 
1.1 Antibiotics in the aquatic environment 
The increasing worldwide contamination of freshwater is a crucial environmental problem asking 
for sustainable global strategies and solutions. Micropollutants are an important matter in the 
contamination of surface and ground waters [1, 2]. Considering freshwater as a source of food, 
drinking water and recreation this concerns not only environmental aspects but also economic 
and social interests [1, 3]. 
Antibiotics are part of the micropollutants occurring only in low concentrations but having still an 
ecotoxicological hazard potential [1, 4]. The antibiotics originate mainly from the medical 
treatment of humans as well as from agriculture. Antibiotics used for the treatment of human 
infections are excreted by urine and faeces and reach the surface water by incomplete extraction 
from the wastewater at the STP or by the direct release into the environment during rain events 
through combined sewer overflows (CSO) [2, 4, 5]. One of the main problems related to 
antibiotics in the aquatic environment is the emergence of bacterial resistance [1, 6, 7]. 
In the review of Schwarzenbach et al. [1] three broad scientific challenges concerning 
micropollutants in the aquatic environment are discussed addressing this issue not only in the 
frame of environmental protection but also in the context of human health in a sustainable sense. 
Firstly, the micropollutants’ impact on the aquatic environment is to be assessed. Secondly, their 
impact is to be reduced and the water contamination by micropollutants should be avoided by 
appropriate treatment technologies, and thirdly a preventive management of water quality is to be 
achieved by a fewer introduction of micropollutants through more environmentally friendly usage 
and disposal strategies. To assess the ecotoxicological impact of antibiotics in the aquatic 
environment and to find good strategies to treat wastewater and contaminated sites it is important 
to have thorough knowledge about the distribution and fate of the antibiotics and at what 
concentration they occur in the aquatic environment [1, 3]. 
In that context, antibiotics measurements can be very contributively. Models are against this less 
suitable for predicting concentrations for real world situations. If however, good information on 
consumption and excretion is available there can be good agreement between modelled and 
measured values. Models can be very cost-effective compared to measurement campaigns for 
example when it comes to investigations in larger areas or if the concentration of a given pollutant 
is very low and difficult to measure [3]. So, both, measurements and modeling are helpful methods 
for a better and detailed understanding and quantification of antibiotics in the environment but 
they are not equally suitable for all applications. 
Introduction 
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They are also the tools chosen in this study to investigate the antibiotics dynamics in wastewater. 
The measurements are used to analyse the antibiotic occurrence at the hourly, daily and monthly 
time scale. The model concentrates on short-term variations within a day. 
 
 
1.2 Antibiotics measurements 
There are a lot of studies having effectuated micropollutant measurements in wastewater 
quantifying them in the wastewater, activated sludge or STP effluent [8], [5]. They either explore 
the fate of the micropollutants in the wastewater like also the present study, or they investigate on 
sampling methods of micropollutants [9], [10]. Table 1 shows some examples in more details. 
Depending on the purposes of a measurement campaign a certain sampling mode is chosen. When 
for example the occurrence of a substance is to be proved the grab sampling mode can be applied. 
In this case one or a number of samples are taken independent of time, the wastewater flow rate 
or to each other. When the development of the concentration of a micropollutant in wastewater 
for a certain time period (e.g. during 24 hours) is being analysed, the continuous flow-proportional 
sampling mode or the discrete flow-proportional sampling mode with a high sampling frequency 
should be chosen. Since the flow rate in a sewer is very probable to vary significantly in the course 
of the day it is continuously measured and the wastewater is collected depending on the measured 
flow rate. In the case of discrete flow-proportional sampling a certain number of subsamples 
containing each a flow-proportional amount of wastewater are put together to obtain a composite 
sample. Composite samples then represent the average micropollutant concentration of the time 
period during which their subsamples have been collected [9]. 
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Table 1: Studies in which micropollutant concentrations in wastewater were being measured to investigate sampling methods or the origin and fate of micropollutants in the 
wastewater, STP or in the environment 
References Goal / Substances Sampling mode Sampling 
frequency 
Sampling 
period  
Sampling location Measuring unit 
Ort, Lawrence, 
Reungoat et al. 
(2010) [10] 
Comparison of 
different sampling 
modes and optimisation 
 
Substance: Gadolinium 
Diverse, for example: 
• grab sampling 
• continuous flow-
proportional sampling 
• discrete volume 
proportional sampling 
• discrete time-
proportional sampling 
 
• 2 min 
• - 
 
• 1 per 400 m3 
 
• 1 per hour 
 
• 4 hours 
• 5 days 
 
• 5 days 
 
• 5 days 
Influent of STP (gravity-
fed, 100’000 inhabitants, 
separate sewer system) 
 
• Load [g/min] 
• Concentration 
[µg/l] 
• Concentration 
[µg/l] 
• Concentration 
[µg/l] 
Managaki et al. 
(2008) [5] 
Diurnal behaviour of 
pharmaceuticals and 
gross organic pollutants 
Diverse Substances, 
among others: 
• Sulfamethoxazole 
• Clarithromycin 
• No declaration 
• No declaration 
• 30 minutes 
• 1 hour 
• 24 hours 
• 24 hours 
Influent of STP 
(5500 inhabitants, 
combined sewer system 
(± dry weather 
conditions)) 
• Load [µg/s] 
Plósz et al. 
(2010) [8] 
Diurnal variations and 
fate of hormones and 
antibiotics  
Hormones: 
• Estrone 
• Estriol 
Antibiotics: 
8 hours flow-
proportional composite 
sampling  
• 15 minutes • 3 days • Effluent of primary 
clarifier (≈ pre-clarified 
influent of STP) 
• Effluent of Anoxic and 
aerobic treatment tank 
(≈ effluent of STP 
• Load [g/8h] 
• Concentration 
[ng/l] 
Introduction 
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• Ciprofloxacin 
• Sulfamethoxazole 
• Trimethoprim 
• Tetracycline 
Heberer et al. 
(2005) [11] 
Contribution of 
hospital and household 
effluents to total load of 
• Carbamazepine 
• Diclofenac 
24 h composite 
sampling, no declaration 
about time-, volume- or 
flow-proportional 
sampling but flow rate 
was measured 
continuously 
• No 
declaration 
• 7 days • Hospital effluent 
• Sewage pumping 
station(96’000 
inhabitants, 4 
additional hospitals 
• Influent and effluent of 
STP (1 Mio inhabitants 
+ 12060 hospital beds) 
• Load [g/week] 
Göbel et al. 
(2007) [12] 
Fate of antibiotics in 
different wastewater 
treatment technologies, 
among others: 
• Azithromycin 
• Clarithromycin 
• Trimethoprim 
• Sulfamethoxazole 
• 24 h composite flow-
proportional sampling 
• Ditto 
• Ditto 
• Ditto 
• Ditto 
• Grab samples 
• No 
declaration 
• 1 week • raw influent of STP 
• effluent of primary 
clarifier of STP 
• effluent of secondary 
clarifier of STP 
• effluent of sand filter 
•  other places in STP 
(55’000 population 
equivalents, combined 
sewer system) 
• Concentration 
[µg/l]  
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1.3 Modelling of antibiotics 
There are also some examples of models predicting the concentration of different micropollutants 
at the STP inlet, effluent or in the environment (see Table 2) [13], [14], [15], [11]. According to 
Johnson et al. [3] a model should contain information about consumption and excretion to obtain 
reliable results. Some of the models presented in Table 2 go even more in detail by taking into 
account also the mode of application (oral, dermal etc.) and the transformations or losses during 
sewer transit [11, 13].Nevertheless, none of the models predicts the micropollutants load on a 
temporal resolution of less than one day as it can be seen in Table 2. 
Table 2: Studies in which micropollutant concentrations in wastewater were being modelled on different 
temporal resolutions 
References Temporal 
resolution 
Substances Result / remarks 
Johnson et al. (2004) 
[13] 
1 day Steroid estrogens: 
• Estradiol 
• Estrone 
• Ethinylestradiol 
Concentration in the STP influent 
and effluent 
Rowney et al. (2009) 
[14] 
1 day Diverse; among others: 
• Azithromycin 
• Ciprofloxacin 
• Clarithromycin 
• Trimethoprim 
Mass flow rate (MFR) in the STP 
influent, concentration in the 
effluent and in the environment as 
well as drinking water exposure 
Ort et al. (2010) [15] 1 day • Carbamazepine 
• Diclofenac 
MFR in STP influent and effluent 
and in the environment 
Consumption data assumed to be 
evenly distributed throughout the 
year 
Heberer et al. (2005) 
[11] 
1 week • Carbamazepine 
• Diclofenac 
Mass flow rate in the effluents of 
military hospital, sewage pumping 
station (= MFR in the waste water 
before STP) and municipal STP 
 
 
1.4 Objectives 
There are studies pointing out that antibiotics concentrations in wastewater show seasonal 
variations [7] [16] [17]. In contrast to these long-term variations, short-term variations are not 
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very properly known yet and as seen before, they are not predicted by the models considered in 
Table 2, nor has there been found any other model predicting micropollutants concentration on a 
high temporal resolution in the course of this study. However, they are important for the accuracy 
of research. A concrete example is the choice of the sampling frequency for antibiotics 
measurements which depends on the frequency of concentration variations [9]. And also in the 
context of environmental impacts a proper knowledge of short-term variations is important be it 
for example for the optimisation of modern removal techniques of micropollutants as well as in 
the context of the direct inflow into surface waters by CSOs [18]. 
The measurements used in this study allow analysing the antibiotics dynamics at the monthly, 
daily and hourly time scale. The objective of the analysis of the measurements is to 
identify the dominant time scale of antibiotics concentration variations in the wastewater. 
 
Considering the antibiotics short-term variations in the wastewater being still quite unknown and 
that there has not been found a model predicting and investigating them the second objective of 
this study is to  
create a model simulating the short-term concentration variations of several antibiotics in 
the wastewater that is to say at the STP inlet. 
 
In the next chapter the measurement campaigns that were being carried out are explained. Then, 
it is presented how the model is designed. In the chapter about the results, first, the outcomes of 
the analyses of the measurements are presented and afterwards the model results are shown. The 
conclusion finally resumes the main findings of this study. 
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2 Experimental design 
2.1 Local situation and campaigns 
Between December 2010 and February 2012 several antibiotics measurement campaigns were 
carried out at the inlet of the STP of Vidy in Lausanne in order to analyse monthly, daily and 
hourly mass fluxes. The STP of Vidy treats around 110’000 m3 every day which corresponds to 
about a 220’000 population equivalent. The wastewater arises from the households of Lausanne 
and 15 surrounding communities and from several hospitals. The sewer network is partially 
separated and so the wastewater contains occasionally also storm water and water from the two 
rivers le Flon and la Louve. Figure 1 shows the catchment basin of the STP of Vidy whose area is 
about 74 km2 [19]. 
 
Figure 1: Catchment basin (colored areas) and communities (bordered areas) connected to the STP (STEP) of 
Vidy [19] 
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There are two types of campaigns which were being carried out. They are explained in the 
following section from Coutu et al. [18]: 
• A yearlong field campaign was conducted at the wastewater treatment plant (WTP) 
entrance, following the recommendations of Ort et al. [20]. Starting in March 2011, 12 
(i.e., once each month) week-long sampling campaigns were conducted. A week-long 
experimental campaign consists of seven daily-composite samples, for the seven 
consecutive days of the week. A daily-composite sample was obtained by mixing (flow 
proportionally) 24 hourly samples of 200 ml, collected with an automatic sampling device 
(6712FR Teledyne ISCO). Collected samples were stored on-site in plastic bottles inside 
the refrigerated sampling device at a temperature below 4°C before collection for 
laboratory analysis. Samples were analyzed or frozen at -20°C within 24 hours after 
collection. Eighty-four samples were collected during this first campaign. 
• Alongside this yearlong campaign, four 24-h campaigns were conducted to evaluate the 
dynamics of antibiotics mass flux at hourly scale. The four campaigns were conducted 
during the four seasons: winter (December), spring (May), summer (September), autumn 
(November). A 24-h campaign provided 24 samples, one per hour, starting at 7:00am. Each 
hourly sample was composed from four 200 ml wastewater samples collected every 
15 minutes. Ninety-six samples were collected within this campaign.  
 
The different field campaigns are summarized in Table 3. All samples were collected at the 
same location using the same sampler. Water samples were analysed using online SPE 
UPLC-MS/MS, and concentrations were obtained for six antibiotics – trimethoprim, 
norfloxacin, ciprofloxacin, ofloxacin, clindamycin, metronidazole (>1000 analyses).  
In summary, the sampling program allows the comparison of mass flux fluctuations 
month-to-month, day-to-day and hour-to-hour, thereby providing information on the 
time scales that control antibiotic fluxes in wastewater. 
 
Table 3: Description of the methodology used to obtain the monthly, daily and hourly samples in the 
field campaign. Samples were all collected at the same location of the WTP entrance. 
 
 
Apart from the measurement campaign of the 06.12.2010 the measurement campaigns were 
carried out under dry weather flow conditions. 
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In the following sections from Coutu et al. [18] the flow measurements, the sample treatment and 
analysis of active compounds as well as the data analysis are presented: 
2.2 Flow measurements 
An ultrasonic sensor was installed next to the automatic sampler device to record the wastewater 
levels at 5 min time intervals. The water level was later converted into flow by use of the 
appropriate calibration1. 
 
2.3 Sample treatment and analysis of active compounds 
A method proposed by Morasch et al. [21] was adapted to measure antibiotic concentrations in the 
WTP influent samples. The methodology has proven in the past its ability to quantify 
micropollutants in environmental matrices [21, 22]. As a first step samples were acidified 
approximately to pH 2 to 2.5 with hydrochloric acid (concentrated 25%). Then, samples were 
filtered, first, through 2.7 µm glass fibre pre-filters (type GF/D, Whatman). The pre-filtered 
samples were filtered again through 0.45 µm membrane filters (type ME 25, mixed cellulose ester, 
Whatman). The samples were stored at -20◦C until analysis. 
The analytical method involves online solid-phase extraction (SPE) and Ultra Performance Liquid 
Chromatography coupled with tandem mass spectrometer (Xevo UPLC-MS/MS, Waters). Prior to 
analysis, frozen samples were brought back to room temperature a few hours. 8 mL of each sample 
was filtered through 0.2 µm syringe filters (type GMF, BGB-analytik) directly into the injection 
vials. Then, a mixture of deuterated antibiotic surrogates was added with gas-tight syringe into all 
injection vials (samples as well as standards). Targeted compounds were first extracted in the 
online SPE system, which consists in a 2.1×20 mm SPE column (type Oasis HLB 25 µm, Waters). 
Extracted compounds were separated in a 2:1×50 mm chromatographic analytical column (type 
Acquity UPLC BEH C18 1.7 µm, Waters) with an organic mobile phase in gradient mode. All the 
targeted compounds were identified and quantified in tandem mass spectrometry according to 
their masses of precursor and product ions as well as their mass-to-charge ratio. 
The analytical limit of quantification (LOQ) was defined as the concentration of the lowest 
standard with a signal-to-noise ratio greater than 10 [22]. The antibiotic concentration in the 
samples was calculated based on calibration curves using seven calibration points closest to the 
sample concentration. Correlation coefficients for the calibration curves were typically set to 0.99 
at least. In the calculation of sample concentration, recovery rates of deuterated surrogates and 
exact sample mass weighed during sample preparation were taken into account for each associated 
antibiotic compound. 
                                                     
1 http://www.isco.com, site last accessed in June 2012 
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2.4 Data analysis 
Only mass fluxes of antibiotics are discussed. As some sampling was performed in rainy periods, 
dilution would have produced low concentration measurements. Hereafter, we use the term 
“measured mass flux” to indicate the mass flux obtained by multiplying, for each sample, the 
measured flow and measured concentration.  
Statistical techniques were used to assess potential temporal patterns in mass flux fluctuation and 
the relative importance of the different time scales (m, d, h) in antibiotics mass flux dynamics at 
WTP inlet. They were carried out using Matlab (2009b, The Mathworks, Natick, MA). 
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3 Modelling 
3.1 Design of the model of antibiotics concentration at STP inlet 
The objective is to simulate the antibiotics concentration at the STP inlet with a temporal 
resolution of one hour. In a first step a model for short-term antibiotics discharge into the sewer is 
composed. Afterwards, it is coupled with an existing model simulating the flow rate in the sewer 
network to get the antibiotic concentration in the wastewater or at the STP inlet. This basic idea 
can be expressed a little more analytically the following way: 
		
 =
 ∗
100 − 
100

			 (1)  
CAB STPinlet :  Antibiotic concentration in the wastewater at the STP inlet on an hourly basis in 
[mass/volume] 
rABdischarge:  Hourly antibiotic discharge rate into the sewer in [mass/time(hour)] 
k:  Transit loss fraction [%] 
Qsewer:  Waste water flow rate in the sewer [volume/time] resolved in time steps of ten 
minutes 
 
The antibiotic discharge rate describes the mass of antibiotic flowing every hour into the sewer 
network. The models briefly described in section  1.3 estimate this amount based on data on 
consumption and excretion of the medicament. Since this model concentrates on short-term 
variations, the model inputs about consumption and excretion have to be in a high temporal 
resolution. Therefore, the excretion is subdivided into the physiological excretion rate into the 
urine and the time when the toilet is used so that the loaded urine enters then the sewer system. 
Thus, the hourly antibiotic discharge rate is finally a function of the amount and time of intake of 
the antibiotic, its accumulation in the urine and the time of toilet use. 
The transit loss fraction gives an estimate of the fraction of antibiotics getting lost during sewer 
transit for example by sorption to the biofilm in the sewers or biodegradation [17, 23, 24]. 
The waste water flow rate is predicted using the already existing hydrological model created by 
Dario Del Giudice in his master thesis in 2011 (see [25]). One part of his master thesis consisted in 
the development of a hydrological model predicting the flow rate in the sewer system and its 
application on the sewer catchment of Lausanne. He described the model among other things as 
being lumped, deterministic and continuous. This means it treats the catchment area as one unit 
not considering spatial variations of variables and parameters. As a deterministic model it does not 
account for random variables with probability distributions and gives as output only one solution. 
Furthermore it simulates the hydrosystem’s behaviour over a certain time period and hence, it is a 
continuous model [25]. 
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Borrowing the idea of this classification the present antibiotics discharge model can be described 
as a lumped, stochastic and continuous model. In contrary to his model this one is stochastic 
because a Monte Carlo approach is used combining different probabilistic curves: The probability 
distribution of the time of antibiotics intake, of the number of toilet uses a day and the probability 
distribution of the time of toilet use. A Monte Carlo method uses deliberately random numbers in 
calculations with the structure of stochastic processes [26]. In this case it means that for example 
the time when somebody goes to the toilet is picked randomly but weighted following a certain 
probability distribution. The time of the antibiotic intake, the number of toilet uses a day and the 
hours when the toilet is used are determined this way and separately for the estimated number of 
persons consuming the medicament at a certain day. Then, the amount of antibiotic discharged is 
calculated for the considered day. This way, a nonprobabilistic problem can be solved by use of 
probabilistic methods [26]. 
The following subchapters describe first, how the antibiotic discharge model is constructed, then 
how it is coupled with the transport model and finally how the whole model is calibrated and 
validated. The entire labour is effectuated by using Matlab2. 
 
 
3.2 The antibiotics discharge model 
3.2.1 Antibiotics consumption data 
The consumed amount of antibiotics is an essential input for the model. However, direct 
consumption information does not exist. For that reason it is assumed that the consumed amount 
corresponds to the sold amount of the prescribed antibiotics. The model created is applied for the 
catchment area of the STP of Vidy in Lausanne. For this area there are no data available that 
comprise the amounts of prescribed antibiotics from all private and public health centres. Hence, 
this information is deduced from the monthly sold amounts of prescribed antibiotics. The 
interpolation of the data provided by the Professional Cooperative of Swiss Pharmacist (OFAC) 
allowed getting an estimate for the ambulatory antibiotics sales. Data provided by the pharmacy of 
the university hospital centre of the canton of Vaud (CHUV, centre hospitalier universitaire 
Vaudois) enabled the estimation of the antibiotics amounts used in the hospitals. 
The model is applied for three antibiotics: ciprofloxacin, norfloxacin and trimethoprim. For 
ciprofloxacin and norfloxacin it is assumed that tablets of 400 mg and 500 mg respectively are 
administred two times a day [8, 27, 28]. Trimethoprim is assumed to be administered by four 
tablets of 160 mg (960 mg Bactrim) a day. Especially for trimethoprim this assumptions include 
uncertainties because the antibiotics are prescribed in different amounts depending on the disease 
and the age of the patient [28, 29]. 
                                                     
2 Matlab versions 7.9.0.529 (R2009b) and 7.10.0.499 (R2010a)  
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3.2.2 Time of antibiotics intake 
 For the consumption time a probability distribution throughout the day has to be found. No 
general information is found on the medicament intake habits of patients. There is information 
however on the (ideal) frequency of the medicine administration such as the administration 
instructions that can often be found on the packages of prescribed medicaments. So, the intake 
probability distribution is estimated based on such information. However, they just indicate the 
daytimes when (e.g. morning – evening) or the number of times a day a medicament should be 
administered and not precise hours.  
The first antibiotics intake a day is assumed 
to happen in the same hour as the first toilet 
use. The succeeding intakes are picked 
randomly but weighted after a normal 
distribution with their mean values as many 
hours later as a perfectly regular 
administration would allow for (see example 
given in Figure 2). The standard deviation of 
the normal distribution is unknown. It is 
arbitrary assumed to be between one and 
seven hours and determined through the 
calibration. 
 
 
3.2.3 Accumulation in the urine 
After the intake of an antibiotic such as norfloxacin or ciprofloxacin it is partially absorbed, 
distributed and metabolised in the body [31]. The elimination of the metabolites as well as of the 
unchanged agent happens via urine or faeces but the excretion in urine is predominant for a lot of 
pharmaceuticals [4] [32]. In the case of ciprofloxacin about 40 to 50% of the oral dose is excreted 
unchanged in the urine and about 20-30% are excreted not metabolized in faeces [4, 30, 31, 33]. 
Of Trimethoprim about 50 to 75% of a dose is excreted unchanged in the urine (Kasamen et al., 
1978 cited in [34]) and less than 4% are present in faeces (Schwartz et al., 1969 cited in [34]). 
Norfloxacin on the contrary is in higher amounts excreted by faeces than by urine. About 25 to 30 
% of the oral dose is excreted unchanged in the urine and 30 to 40% are excreted unchanged via 
faeces [4, 30, 31, 33]. Figure 3 shows exemplarily the cumulative urinary excretion of 
unmetabolised norfloxacin after single oral doses. For the model such curves are found and 
extrapolated for the considered antibiotics with the corresponding pill masses. The model 
concentrates on unmetabolised antibiotics because metabolites were not being measured in the 
measurement campaigns. In addition, for most drugs the toxicity is reduced for metabolites 
compared to their parent drug [4] which makes them more important in an environmental point 
of view. 
 
Figure 2: Example for the intake probability 
distribution of the second administration having had 
the first one at 8 am (red arrow) in the case of 
2 administrations a day (= 12 h-interval in-between); 
the standard deviation is here assumed to be 2 
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The excretion or accumulation curves found in literature 
that were viable for the model are the curves of 
ciprofloxacin, norfloxacin and trimethoprim and they all 
concern only the urinary accumulation. For that reason the 
accumulation in faeces is not considered in the model. The 
found urinary accumulation curves are all originating from 
studies investigating among others the renal excretion after 
single doses only. However, for disease treatment patients 
might often be advised to take the antibiotic for several 
days. Based on the study of Ledergerber et al. [35] it can be 
said that the urinary accumulation of ciprofloxacin does not 
change strongly with multi-doses prescriptions. Norfloxacin 
has about the same half-life time as ciprofloxacin [35], [36] 
and shows only little accumulation in the human body [31]. 
Thus, it can be assumed that just as for ciprofloxacin the 
urinary accumulation of norfloxacin does not change 
considerably with multiple doses compared to a single 
application. 
The information found on the urinary accumulation of 
ciprofloxacin is not as precise as for norfloxacin. The 
standard errors of the means of norfloxacin are not exceeding 10% of the means as it can be seen 
in Figure 3. In the case of ciprofloxacin these variances are up to around 60% of the measured 
mean. If accumulation mass values are assumed to be 60% higher compared to the average, then 
the concentration modelled at the STP inlet increases also to about 60%. This is accounted for 
during the model calibration by applying a substance-specific parameter accounting for such 
variations. 
In literature the urinary accumulation after oral administration as well as after intravenous 
administration is documented. Depending on such an application mode the dynamic of the 
urinary accumulation can be slightly different [33]. For the model the intravenous administration 
is not considered. According to the amount of prescribed antibiotics in the Canton of Vaud there 
were no sales from 2006 to 2010 of norfloxacin and trimethoprim medicaments for intravenous 
application. In contrast, ciprofloxacin was being sold in the form of intravenous medicaments. The 
mass of ciprofloxacin intravenously administered accounts for about 15 to 20% of the total mass 
sold. Considering this rather not so high amount and the hypotheses that must be made to account 
for the slight differences of this application mode in the urinary accumulation (there is for 
example no reliable way to find a probability distribution for the time of injection) it is decided 
not to treat it separately. Instead, the amount of ciprofloxacin intravenously administered is 
assumed to be orally administered. 
 
 
 
Figure 3: Cumulative urinary excretion 
of unmetabolized norfloxacin after 
various single oral doses: 200 mg (), 
400 mg (), 800 mg (), 1200 mg () 
and 1600 mg (). Points and bars 
indicate means ± standard errors of 
the means. [30] 
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3.2.4 Time and mean number of daily toilet uses 
The time when the toilet is used is always the time when antibiotics are discharged into the sewer. 
In that sense, the time of toilet use plays an important role for the model.  
Based on Rauch et al. [37], Friedler et al. [38] and Rossi et al. [39] a distribution of toilet use 
throughout the day is assembled. These studies investigated among others the diurnal urine load 
entering the sewer and the (domestic) toilet use by surveys or by measurements. According to 
Friedler et al. [38] and Rossi et al. [39] not all but the majority of the flushes were related to urinal 
use. This is important because the model only considers urinary antibiotics discharge. 
The frequency diagrams of the three mentioned studies are shown in Figure 4a)-c). 
 
Figure 4a): Frequency diagram of diurnal toilet use by Rauch et al. [37] 
 
Figure 4b): Diurnal pattern of toilet flushes by Friedler et al. [38] 
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Figure 4c): Toilet use profile for four different apartments during weekdays by 
Rossi et al. [39] 
 
The assembled toilet use distribution is presented in Figure 5. 
 
Figure 5: Assembled toilet use probability distribution. The sum over 24 hours 
amounts to 100% 
 
 
Indications about the number of toilet uses 
per day can be found in the studies of 
Friedler et al. [38] and Rossi et al. [39] (see 
Table 4). Taking into account that not all 
flushes are due to urinal use and that these 
numbers refer to domestic toilet use 
suggesting a probable underestimation since 
people might use toilets also outside of their 
households, the mean number of toilet uses 
per day and person could be estimated to around 6. The standard deviation is assumed to be 
around ±2. Since the two values are quite uncertain they are not directly introduced into the 
model as they are. Instead, the mean number of toilet uses a day and its standard deviation are 
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Table 4: Literature values on average number of toilet 
uses per capita and day and its standard deviation 
 Friedler et al. 
[38] 
Rossi et al. [39] 
Weekdays 3.98 ± 3.30 5.2 ± 1.2 
Weekend 
days 
4.75 ± 2.79 5.6 ± 1.4 
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calibrated. The two values found in literature served as reference points for the definition of the 
range in which the calibration should take place (see section  3.4). 
 
 
3.2.5 Model procedure 
As briefly explained in section  3.1 the time of antibiotic intake as well as the mean number of 
toilet uses a day and the corresponding time is found randomly but weighted depending on the 
probabilities presented in sections  3.2.2  3.2and  3.2.4. Once having obtained these parameters for 
one day, the antibiotics’ mass entering the sewer system can be found. For every hour when the 
toilet is used the antibiotics mass released is found by calculating the difference of the 
accumulated antibiotics in the urine since the previous toilet use (see Figure 6). 
This random parameter determination and antibiotic discharge calculation is repeated for the 
number of days of the considered time period and the estimated number of persons a day 
consuming the antibiotic. This latter number could be estimated by means of the data base of sold 
antibiotics in the Canton of Vaud. The available data on the antibiotics consumption reaches from 
2005 to 2010 and is indicated as mass per month. For every month the average consumption of 
these five years is calculated. By assuming that the consumption is evenly distributed throughout 
the month the daily consumed mass is found. This assumption is likely to have little impact on the 
final model results since seasonal variations as well as the variations within the day are generally 
more important than the variations from one day to another as it is explained in section  4.1. 
Finally, the hourly mass distribution of antibiotics discharged by a person a day is summed up for 
the estimated number of consuming persons a day. This way, the hourly antibiotic mass entering 
the sewer system over the considered time period is found (see again Figure 6). 
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Figure 6: Illustration of the calculation of the hourly antibiotics discharge out of the urinary accumulation and 
the random discharges of single persons 
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3.3 Antibiotics transport to STP and coupling with transport model 
3.3.1 Transit loss fraction 
During the transport from the toilet to the STP parts of the antibiotics in the wastewater probably 
get lost. A process likely to happen is the sorption of the antibiotics to biofilms in the sewer 
system. In laboratory conditions the sorption rates of different substances are quite diverse [23]. 
There is no detailed information available about sorption rates of antibiotics in sewers or other 
processes impacting their concentration at the STP inlet. To account for such losses anyhow, the 
transit loss fraction k is introduced. Its value is a priori unknown and can vary between 0% and 
100%. Later on, by calibrating the model a value is found for k. 
 
 
3.3.2 Travel time 
The travel time is the time it takes the wastewater that is to say also the antibiotics to go from the 
toilet to the STP. It leads to a delay of a certain antibiotic wave from its discharge to its arrival at 
the STP. In their study Ort, Lawrence Reungoat et al.[10] estimated the travel time of a certain 
renal excreted micropollutant from the toilet to the STP inlet to get an idea about the time when 
the peak of the micropollutant could be expected at the STP inlet. Instead of estimating the 
wastewater travel time in the catchment of Lausanne’s STP it is introduced into the model as an 
a priori unknown constant, just as the transit loss fraction. Then, it is determined by the 
calibration. Since the catchment area is inclined which suggests a rather short travel time it is 
assumed to be two hours at most and zero if it is less than one hour. 
 
 
3.3.3  Transport model coupling 
For modelling the flow rate in the sewer network the transport model needs as input the 
temperature and rain data for the considered period. These data are obtained from the weather 
station in Pully kept by MeteoSwiss. Where data are missing (rain data from the 13.07.2011 to the 
20.07.2011) they are replaced by the data of the weather station in Bière which has a linear 
distance to Lausanne of around 20 km. 
The wastewater flow rate (Q) resulting of the transport model is given in cubic meter per seconds 
in time steps of ten minutes. So, the modelled hourly antibiotic discharge rate is converted as well 
in mass per second and time steps of ten minutes and then divided by the flow rate (see 
equation 2). This way, the antibiotic concentration (C) in ten minute time steps at the STP inlet is 
received and averaged afterwards to the mean hourly concentration. 
	[!"/$]
	[!&/$]
∗ 1000['"/!"] = 	['"/(] 
(2)  
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3.4 Model calibration and validation 
In accordance with Dario Del Giudice’s procedure with the transport model, here too, a model 
calibration by means of the Nash-Sutcliffe efficiency coefficient (NS) and the normalized bias (NB) 
is applied. These are helpful tools to evaluate the accuracy of data simulated by watershed models. 
They both compare modelled data with observed values [40]. 
The Nash-Sutcliffe efficiency is calculated as follows [25, 40]: 
)* = 1 −
∑ (-
./ − -
0)	23
4
∑ 5-
./ − -./6666667
4	
23
 (3)  
 
n: number of values in considered calibration period 
-
./: observed value at time i 
-
0: simulated value at time i 
-./666666: mean observed values over the period from i=1 to n 
The resulting values range from -∞ up to 1.0 whereby NS = 1.0 is the optimal value. 
 
The normalized bias is defined as follows [25, 40]: 
)8 =	
∑ (-
./ − -
0)	23
' ∗ -./66666
 
(4)  
 
Values can be positive or negative indicating under- or overestimation of the modelled values. The 
optimal value is 0.0. 
 
During the calibration these two coefficients are combined in a way that a single optimal value 
(Vopt) is found which is evaluating the simulation, (based on [25]): 
9.: = ;)<(1 − )*) + |)8|? (5)  
The model is run several times, every time with different parameter values randomly chosen. 
Hence, again a Monte Carlo approach is applied. After every simulation Vopt is calculated and 
compared to the Vopt of the best previous simulation. If it is higher than this previous best Vopt it is 
rejected. Otherwise the applied parameter set will show a better fit of modelled to measured 
values and so it is saved. 
 
For calibrating the model of the present work the measurement campaign of autumn 2011 is 
chosen. This means that the 24 measured concentration values of the 6th September 2011 (n=24) 
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are compared in every model run to the 24 values simulated for the same day. The measurement 
campaign of autumn is chosen because it was effectuated in dry-weather conditions and shows 
generally a regular journal concentration pattern (see section  4.1.2). 
The model is run 10’000 times for every substance. The parameters that are varied in every run are 
parameters within the model that are fraught with substantial uncertainties such as the transit loss 
fraction. Table 5 resumes the parameters that are considered as uncertain and are varied during 
the model calibration. For each of them a range of possible values is chosen where possible based 
on literature values. Out of the determined range the parameter values are chosen randomly. The 
discretisation step of each parameter stands for the interval between two values a parameter could 
have and hence decides also how many possible values a certain parameter could take on. 
The parameter determining the order of magnitude of the urinary accumulation curve can in all 
cases be higher than 100%. The accumulation curves found in literature are not strict curves. They 
have bars showing standard errors pointing to analytical uncertainties or bars illustrating the 
standard deviation of the samples which are due to differences in the metabolism of individuals. 
This is tried to account for by submitting this parameter to the calibration. 
As mentioned, the calibration is conducted for all substances separately since the variations of the 
urinary accumulation as well as the sorption to the biofilms and the biodegradation resumed in 
the transit loss fraction are not the same for all substances. 
 
Table 5: Calibrated parameters with ranges of plausible values 
Parameters Literature 
values 
Value ranges Discretisation 
steps 
Urinary accumulation  % of values on accumulation 
curve 
 
Ciprofloxacin See appendix 3% – 150%  1% 
Norfloxacin See appendix 85% – 115% 1% 
Trimethoprim See appendix 70% – 130%  1% 
Mean number of toilet uses 
a day 
6 3 – 12 1 
Standard deviation of 
number of toilet uses a day 
2 1 – 5 0.1 
Standard deviation of time 
of the subsequent intake(s) 
- 1 – 7 hours 0.1 hour 
Transit loss fraction - 0% – 100% 1% 
Delay due to transit - 0 – 2 hours 1 hour 
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In the model validation the model is run with the parameter set which is found to be best fitting 
in the calibration. The resulting values are then compared with the measurements of the three 
remaining seasons winter 2010, spring 2011 and summer 2011. 
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4 Results 
4.1 Experimental results 
The presentation of the measurement results is again extracted from Coutu et al. [18]: 
4.1.1 Seasonality of mass flux 
The experimental campaign was designed to identify seasonality in the mass flux of antibiotics in 
wastewater. For this purpose, mass fluxes measured monthly at the WTP inlet are compared 
throughout the year. Seven consecutive daily samples are aggregated flow proportionally to form a 
monthly sample (see Table 3). The median mass flux obtained is presented for each month and all 
substances in Figure 7. The minimum monthly mass fluxes are generally found during the period 
running from June to September. Mass fluxes measured in December and January have 
systematically higher values except for ciprofloxacin. High values are also observed in March for 
ciprofloxacin, ofloxacin and clindamycin. Curiously, a drop in mass fluxes is observed for all 
substances (except for ciprofloxacin) in February. We suspect that a problem occurred in either 
the sampling campaign or the analytical procedure during this month. Indeed, we could not 
retrieve concentrations for norfloxacin and metronidazole for this month, which supports the 
hypothesis of a failure in either the field sampling campaign or the laboratory analytical 
 
Figure 7: Boxplot of mass flux for the 6 antibiotics investigated. One box per month. Each box is obtained 
from seven daily samples. The red line shows the median. Upper and lower box limits correspond to the 
75th and 25th percentiles respectively. Upper and lower whiskers correspond to the last datum being 
respectively still within 1.5IQR of the higher and lower quartile. IQR is the interquartile range i.e., the 
difference between the upper and lower quartiles. 
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procedure. 
The monthly mass flux normalized by the annual mean is also helpful to evaluate the seasonality 
of antibiotics, as well as the range of the fluctuation. This relative fluctuation is presented in 
Figure 9a) for the six antibiotics considered. Mean monthly mass fluxes appraise between a quarter 
and double of the mean annual mass flux measured at WTP inlet. Ciprofloxacin, ofloxacin and 
clindamycin present an obvious seasonality of their mass flux, with values in winter being up to 
eight times greater than values in the summer. Trimethoprim, on the other hand, shows a less 
variable monthly mass fluxes over the year, although a higher mass flux is still observed in January 
and December. The behaviour of norfloxacin and metronidazole is somewhat curious; values of 
monthly mass fluxes are located broadly between a quarter and half of the mean, with a sudden 
rise in December and January. A general observation for all substances is that the highest mass flux 
is measured during the (winter) months of December and January. 
 
 
4.1.2 Periodicity in hourly mass flux 
The four 24-h campaigns described in Table 3 were used to evaluate periodicity in the mass flux of 
antibiotics reaching the WTP during dry weather. For this, the measured hourly mass flux at each 
hour was first normalized to the mean for that day (Figure 9c)). This procedure removes any 
seasonal effect that can exist in the dynamics of antibiotics and thus allows the comparison of the 
24-h campaigns, which were conducted once per season. After normalization, the four 24-h 
campaigns were combined sequentially into a series of 96 experimental values. The periodogram 
of ciprofloxacin is shown in Figure 8. 
For all substances considered, two peaks clearly appear in the computed periodogram, which 
indicate that the mass flux of antibiotics has a 12-h return period. According to Figure 9c), the first 
peak occurs between 07:00 and 09:00. This morning peak is up to double the average daily flux 
reaching the WTP. It corresponds to the peak in toilet flushes observed by Friedler et al. [38] and 
Rauch et al.[37]. The second peak occurs 12 h later between 19:00 and 21:00. We observe that this 
peak is less pronounced than the morning peak, and occurs over a broader period, between 17:00 
and 21:00. Its value reaches only up to around 1.2 times the daily mean, except for metonidazole. 
Gain, the more diffuse aspect of this second peak in mass flux corresponds to the one observed by 
Friedler et al. [38] and Rauch et al. [37] in the cycle of toilet flushes. 
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Figure 8: Periodogram of the measured hourly mass flux. Peaks in 
power spectrum observed at 0.042 Hz and 0.083 Hz correspond to 
periods of 24 h and 12 h, respectively. The same periods were 
observed for the other substances. 
 
 
4.1.3 Dominant time scale 
We used mean normalized mass fluxes to compare the temporal dynamics of antibiotics at 
different time scales. All the results are summarized in Figure 9. We immediately observe that 
whereas the monthly and hourly mean concentration can fluctuate between 0.25 and 2 times the 
reference mean — i.e. the annual mean and daily mean mass fluxes —, very little fluctuation is 
observed at the daily scale. Indeed, all daily measured mass fluxes remain located between ±20% 
of the weekly average, the only exception being metronidazole. This indicates that from one day 
to the next, the load of antibiotic load to the WTP is constant, throughout the week. Nevertheless, 
the total load from one month to another can change on the seasonal time scale. Similarly, strong 
discrepancies exist between the hourly loads measured at WTP entrance within a given day. 
The incoming flow at the WTP inlet influences mass flux. In Figure 9, we present the flow 
measured during the campaign at the sampling location. The flow is normalized to the mean flow 
to highlight its relative fluctuation. We can discuss the influence of flow on mass flux for the 
hourly and daily time scale only, as monthly samples are affected by rainwater input that does not 
contain antibiotics. 
Concerning the daily time scale (Figure 9b)), no large fluctuations are present in either the water 
flow or the antibiotic mass fluxes. This observation is reasonable, considering that (i) antibiotics 
consumption does not depend on a specific day of the week as consumers must stick to the 
posology of the substance and, (ii) water use in terms of daily average is nearly constant on the 
weekly timescale, even though a small drop is expected during the weekend, where less industrial 
water is consumed. On the other hand, we see on Figure 9c) that a pattern exists in hourly flow to 
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the WTP. This is due to the toilet flush use cycle identified in Friedler et al. [38] and Rauch et al. 
[37] in addition to other domestic usage. However, hourly flow lies between 0.6 and 1.4 times the 
 
 
 
Figure 9:  Fluctuations of mass flux at different time scales: month a), day b) and hour c). In a), each symbol 
corresponds to the average mass flux of the seven daily samples collected in the corresponding month. In b), 
each symbol corresponds to the average value of the twelve times (one per month) the corresponding day 
was sampled. In c), each point corresponds to the average of the four times (four 24-h campaigns) the 
corresponding hour was sampled. The mass flux is normalized to the total mean mass flux over the 
considered time scale to remove seasonal effects. For example, in a) the monthly mass flux is normalized by 
the mean monthly mass flux measured over one year. Clear variability is observed at the monthly and hourly 
time scales for all substances. No variability is observed at the daily time scale, except for metronidazole. 
The corresponding flow—normalized to the mean flow over the considered time scale — is on each graph 
shown by the blue line. The monthly mean flow includes rainwater peaks in addition to the baseflow. Daily 
and hourly mean flows were selected to include only dry periods. i.e., their fluctuation is not affected by any 
rain input. 
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mean hourly flow. This means that flow into the WTP varies less than the mass flux of antibiotics, 
which is usually between 0.2 and 2.5 times the mean hourly mass flux.  
The dominance of monthly and hourly time scales over the daily time scale in the dynamics of 
antibiotic mass fluxes at the WTP inlet is clearly illustrated by Figure 10. The length of the box 
plot computed for each time scale reveals the dispersion of the measured data. The dispersion of 
the daily mass flux along the week is systematically lower than the dispersion of the monthly mass 
flux considered over the year or hourly mass flux over a day. Daily values are typically distributed 
between ±20% around the weekly mean for all substances, with an exception for metronidazole, 
whose daily variations are of the same order of hourly and monthly variations. For all other 
antibiotics, monthly and hourly variations of mass fluxes exceed daily variations. Measured fluxes 
for these time scales are broadly distributed between 0.2 and 2.5 times the mean. This shows the 
importance of the design of the sampling campaign when analyzing antibiotics in environmental 
samples. Depending on the month or the hour of the field campaign a factor higher than 12 can 
exist between the measured mass fluxes. This is due to two factors. First, the seasonality of 
antibiotic mass fluxes reaching the WTP entrance results from seasonality in antibiotics 
consumption [41]. Second, there are concentration fluctuations on the hourly time scale that can 
be explained partially through the toilet use frequency. 
 
 
Figure 10: Boxplots illustrating the dispersion of the measured mass fluxes for the three different time 
scales (m, d, h). Similar to Figure 9, the mass flux is normalized by the mean mass flux over the considered 
time scale. For each substance, the box on the left is obtained from the 12 mean monthly values (twelve 
values in Figure 9a)), the box in the middle from the seven mean daily values (seven values in Figure 9b)), 
and the box in the right-hand side from the 24 mean hourly values (twenty-four values in Figure 9b)). Boxes 
are computed following the same rule described in Figure 7. 
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4.2 Model results 
4.2.1 Flow rates of transport model 
The transport model is run for the whole year when the antibiotic measurements took place that is 
to say from the 1st of December 2010 to the 30th of November 2011. Figure 11 shows the 
development of the wastewater flow rates in the sewer network leading to the STP of Vidy in 
December 2010. The precipitation as one important factor influencing the wastewater flow rate is 
also inserted. When there is no precipitation the diurnal flow rate pattern is clearly visible. The 
figures for the other seasons can be found in the appendix. 
 
Figure 11: Flow rate in winter (blue) resulting from the transport model with the 
precipitation (in black) which is a predominant factor in the model 
 
 
4.2.2 Calibration 
This modelled wastewater flow rate is then coupled with the antibiotic discharge model as 
described in section  3.3.3. Afterwards, the calibration is carried out (see section  3.4) determining 
the one parameter set out of 10’000 which has the best fit to the measurements of autumn. The 
resulting parameters are presented in Table 6. 
As explained in section  3.4 the values of the parameter calibrating the urinary accumulation curve 
aims to compensate analytical uncertainties in the determination of the curve’s values and 
pharmacokinetic differences of individuals. In case of an underestimation of the antibiotic amount 
a priori set in the model inputs this parameter gets higher than 100% as it is the case for 
ciprofloxacin and norfloxacin. The mean number of toilet uses determined by the calibration is 
rather high. This refers to uncertainties in the determination of the time when the toilet is used as 
a whole. This aspect will be discussed later in section  4.2.5. The standard deviation of the time of 
the subsequent antibiotic intake(s) is higher for ciprofloxacin and norfloxacin. The two substances 
are assumed to be administered every twelve hours while trimethoprim is assumed to be ingested 
01/Dec 06/Dec 11/Dec 16/Dec 21/Dec 26/Dec 31/Dec0
1
2
3
4
5
6
7
8
9
10
Modelled flow rate at WWTP inlet in winter 2010
Fl
ow
 ra
te
  [m
3 /s
]
0
0.5
1
1.5
2
2.5
3
Pr
ec
ipi
ta
tio
n 
[m
m/
h]
Results 
29 
every six hours. From this point of view it is reasonable that the standard deviation for the 
subsequent intake(s) is smaller for trimethoprim. The transit loss fraction rather high for 
trimethoprim compared to the other substances. This parameter seems in that case to reduce the 
trimethoprim amount a priori set in the model inputs. Also this aspect is discussed later in 
section  3.4. 
Table 6: Model parameters found through the calibration 
Parameters Ciprofloxacin Norfloxacin Trimethoprim 
Urinary accumulation 109% 115% 81% 
Mean number of toilet uses a day 12 11 12 
Standard deviation of number of toilet uses a 
day 
2 3.6 4.2 
Standard deviation of the time of the 
subsequent intake(s) 
6.9 6.2 1.1 
Transit loss fraction 10% 11% 55% 
Delay due to transit 0 hours 0 hours 0 hours 
 
Figure 12a)-c) show the graph resulting from the calibration comparing antibiotics measurements 
with the modelled concentrations. The order of magnitude is in all three cases at about the same 
level. However, the detailed temporal dynamic of the modelled and the measured concentrations 
do not correspond very properly with each other. On the one hand this has to do with the random 
character of the model with its Monte Carlo approach. On the other hand a certain mismatch is 
expectable with only 24 measured values to compare during the calibration. 
 
Figure 12a): Comparison of the calibrated ciprofloxacin concentrations with the 
measurements 
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Figure 12b): Comparison of the calibrated norfloxacin concentrations with the 
measurements 
 
Figure 12c): Comparison of the calibrated trimethoprim concentrations with the 
measurements 
 
Figure 13 allows a closer look at these deviations of the measurements. There, for every hour the 
average and standard deviation over the 10’000 runs are calculated. The standard deviation is 
added and subtracted to and from the average value and then they are plotted as grey areas around 
the mean (dark grey) to make it visible if the best fit remains in this variations section. The 
minimum and maximum values are found and plotted as light grey areas, too. 
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Figure 13a): Comparison of measured ciprofloxacin concentrations (pink dashed 
line) and best fitting curve (blue line) of the calibration combined with hourly 
average out of the 10’000 calibration runs (black line). The dark grey zone shows 
the average + and – the standard deviation of the 10’000 runs calculated separately 
for every hour. The light grey zones show the range within hourly maximum and 
minimum values of the 10’000 calibration runs 
 
Figure 13b): The same setting as in Figure 13a) shown for norfloxacin. 
 
Figure 13c): Figure settings of Figure 13a) shown for trimethoprim. 
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For all three substances the areas and the curve of the mean modelled values show a dynamic 
which recalls in principal the toilet use distribution. In the morning and in the evening the 
modelled concentration tends to be higher than in the afternoon and at night. It is not completely 
clear why the increase of the maximum values in the afternoon is stronger than the one in the 
morning. What can be said is that the maximum values generally occur when there is no toilet use 
during quite a long time before. Like this the antibiotics have more time to accumulate in the 
urine and resulting load is then rather high. Considering that the first intake is defined to happen 
at the same hour as the first toilet use and the second one being picked randomly it seems possible 
that the urinary accumulation of these administrations will happen in the course of the day and 
higher loads will get discharged towards the evening. 
The measurements of all three substances do not surpass the maximum values. But only the 
measured trimethoprim concentration values remain within the range of standard deviation of the 
modelled values. As it can be expected the best fitting values are in general closer to the 
measurements than the curve with mean modelled values of all calibration runs. 
 
 
4.2.3 Validation 
With the parameters found through the calibration the model is run for the same time period as 
the transport model that is to say from the 1st of December 2010 to the 30th November 2011. Out of 
this period those days are extracted when the measurements were done and compared to the 
measurements. 
The modelled trimethoprim concentrations agree generally fine with the measurements (see 
Figure 14a)-c)).  
Figure 14a): Comparison of modelled and measured 
trimethoprim concentrations in winter 
Figure 14b): Comparison of modelled and measured 
trimethoprim concentrations in spring 
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Figure 14c): Comparison of modelled and measured 
trimethoprim concentrations in summer 
 
 
The other substances show sometimes much more disagreement between measured and modelled 
values (see Figure 15, e.g. ciprofloxacin in winter, ciprofloxacin and norfloxacin in spring). In 
summer however, for all antibiotics the modelled concentrations are to some extent consistent 
with the measured values (see Figure 15e) and f)). The good agreement in summer might be due to 
the fact that the measurement campaigns of autumn (used for calibration) and summer took place 
in quick succession (less than two months).  
Figure 15a): Comparison of modelled and measured 
ciprofloxacin concentrations in winter 
Figure 15b): Comparison of modelled and measured 
norfloxacin concentrations in winter 
Figure 15c): Comparison of modelled and measured Figure 15d): Comparison of modelled and measured 
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Figure 15e): Comparison of modelled and measured 
ciprofloxacin concentrations in summer 
Figure 15f): Comparison of modelled and measured 
norfloxacin concentrations in summer 
 
For none of the substances and seasons a perfect fit of the very short-term dynamic of the 
modelled and measured values is found. This is however not a big surprise in consideration of the 
calibration plots (Figure 12 and Figure 13) showing an exact reproduction of the hourly 
concentration dynamic neither. 
 
 
4.2.4 Modelled dynamics 
Short-term dynamics of the antibiotics discharge 
The distribution of the time of toilet uses is quite an important component of the model as 
mentioned in section  3.2.4. The daily antibiotic discharge pattern on a monthly average follows 
quite strongly the diurnal pattern of the toilet use distribution. This is illustrated in Figure 16. 
By comparing the mean diurnal patterns of the three modelled substances ciprofloxacin, 
norfloxacin and trimethoprim with each other slight differences from one substance to another 
can be discovered. 
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Figure 16a): Toilet use distribution during one day 
which is a predominant component of the discharge 
model 
Figure 16b): Mean diurnal pattern of the 
ciprofloxacin mass flow rate (MFR) discharged into 
the sewer shown on the example of spring. It shows a 
similar dynamic to the toilet use distribution in 16a) 
  
Figure 16c): Mean diurnal pattern of the norfloxacin 
discharge into the sewer in spring 
Figure 16d): Mean diurnal pattern of the 
trimethoprim discharge into the sewer in spring 
 
This modelled average diurnal dynamic of the antibiotics shows some similarity with the 
measured dynamic explained in section  4.1.2 (Figure 9c)). They both show a first peak in the 
morning and a second one in the afternoon. The morning peak is in both cases clearer and takes 
place within a shorter time frame than the afternoon peak. The measured peak in the morning 
takes place between 07:00 and 09:00. The modelled morning peak arrives rather between 07:00 
and 10:00. The peak in the afternoon can in both cases be located between 17:00 and 21:00. Figure 
17 shows by way of example the quite similar daily pattern of measured and modelled hourly 
norfloxacin load in autumn. 
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Figure 17a): Measured norfloxacin mass flow rate 
from the 02.to the 03. November 2011  
Figure 17b): Average of the modelled norfloxacin 
mass flow rate in autumn (10.10.2011 – 09.11.2011) 
showing a very similar diurnal pattern as the 
measurements (see 17a)) 
 
The model reproduces also seasonal differences of the amount of antibiotic sold, that is to say 
consumed (see Figure 18). Ciprofloxacin for example is sold in higher amounts during winter than 
during spring. Equally, the modelled daily ciprofloxacin discharge in winter is slightly higher 
compared to the one of spring and summer. 
 
 
 
 Figure 18a): Relative seasonal differences of sold antibiotic in 
the case of ciprofloxacin. 100% correspond to the yearly mean 
of the amount of sold antibiotic. 
The seasons are here represented by one month each: winter = 
01.-31.12.2010, spring = 01.-31.05.2011, summer = 10.08.-
09.09.2011, autumn = 10.10.-09.11.2011 
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Figure 18b): Modelled monthly average of the 
ciprofloxacin discharge in winter (01.-31.12.2010) 
demonstrating the discharge model’s precise 
reproduction of the slight seasonal differences in 
sold antibiotic amounts. The values in winter are 
slightly higher than the values in spring (see 18c)) 
Figure 18c): Modelled monthly average of the 
ciprofloxacin discharge in spring (01.-31.05.2011). 
These values are generally a little lower than the 
values of winter 18b). 
 
 
 
Short-term dynamics of the antibiotics occurrence at STP inlet 
In previous section the modelled dynamic of antibiotics going into the sewer are discussed. By 
comparing this dynamic with the modelled concentration dynamic at the STP inlet that is to say 
after the coupling with the transport model it can be stated that the main pattern persists but it is 
much more vaguely. Figure 19 presents this on the example of the ciprofloxacin occurrence at the 
STP inlet but it holds true also for norfloxacin and trimethoprim. Again, there is a clear increase in 
the morning hours and another one in the evening while in the afternoon and at night there is 
only little contribution. Comparing the two dynamics with each other (only the dynamic because 
the ciprofloxacin discharge is given as mass flow rate in mg/h, the flow rate in m3/s and the 
ciprofloxacin occurrence at the STP as concentration in ng/l) the modelled wastewater flow rate 
seems to blur the very regular pattern of the discharge model. The small peak in the afternoon 
seen in Figure 19a) is delayed a little towards the evening and it gets more accentuated by the 
coupling with the flow rate. 
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Figure 19a): Repeated presentation of the development of the modelled 
ciprofloxacin mass flow rate entering the sewer system. 
 
Figure 19b): Modelled wastewater flow rate showing as well a daily cycle which is 
however not perfectly synchronous with the modelled cycle of antibiotics discharge 
leading to a diffusion of the peaks at the STP inlet 
 
Figure 19c): Development of the modelled ciprofloxacin concentrations at the STP 
inlet over the same five days as above (19a)) showing again a diurnal pattern which 
is however more diffuse because of the coupling with the wastewater flow rate. 
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Long-term dynamics of the antibiotics concentration at the STP inlet 
The created model concentrates on short-term dynamics of the antibiotics occurrence in the 
wastewater. But with the available data it can be run for the whole year from the 1st of December 
2010 to the 30th of November 2011. The measurement campaign concentrating on long-term 
antibiotics concentration variations was being carried out from March 2011 to February 2012. So, 
the overlapping period lasts from March 2011 to November 2011 that allows having a look at the 
long-term performance of the model.  
Figure 20 shows in black and grey lines the monthly mean values with the standard deviation 
added and subtracted in grey. The measurements consist of seven daily average values every 
month. Their monthly average is presented in pink dashed lines and their added and subtracted 
standard deviation in light pink dashed lines.  
In general the order of magnitude of the modelled values is more or less consistent with the 
measurements. November shows the best agreement. The measurements used for the calibration 
are not from the same campaign as the measurements presented here. Even so the calibration is 
conducted for November which is the reason for this almost perfect accordance of the average 
values. 
The modelled values show less dynamic than the measurements. This is probably due to the fact 
that not the real antibiotic consumption of the considered time period is given as antibiotic 
consumption input but the monthly average antibiotics sales between 2006 and 2010 instead. This 
aspect is further discussed in the section about the hypotheses of the model design in 
subchapter  4.2.5. Generally the ciprofloxacin and norfloxacin concentrations seem to be 
overestimated by the model while the trimethoprim concentration is rather underestimated by 
the model. 
 
Figure 20a): Comparison of measured (pink dashed lines) and modelled (black and grey 
lines) ciprofloxacin values on the long-term. The pink dashed lines show the measured 
monthly mean consisting of seven daily means per month. The light pink dashed lines 
are the added and subtracted standard deviations. In black the monthly mean of the 
modelled values and in grey their added and subtracted standard deviations are shown. 
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Figure 20b): The same setting as in 19a) for norfloxacin 
 
Figure 20c): The same setting as in 19a) for trimethoprim 
 
Dividing the nine modelled monthly values from March to November 2011 by the nine measured 
values the percentage of the modelled to the measured values is found. The average of the 
percentages over these nine months is calculated for all three substances. The values are presented 
in Table 7 together with the range of these percentages indicating minimum and maximum 
deviations between measured and modelled values. Furthermore in Table 7 the long-term 
performance of the model is compared to the model results of other models. The comparison is 
employed by calculating again the percentage of the modelled to the measured values of two of 
the models presented at the beginning in section  1.3. The first one is the model of Heberer and 
Feldmann [11] predicting diclofenac and carbamazepine loads and the second one is the model of 
Johnson and Williams [13] estimating estradiol estrone and ethinylestradiol concentrations. The 
first of the two models predicts the micropollutant load on a weekly basis. Johnson and Williams 
[13] based their model on daily excretion values (e.g. µg/d). The values consulted here for the 
comparison are given as concentrations (ng/L). In both models the micropollutants were predicted 
at different sites. For the comparison only the predicted and measured values at the STP inlet are 
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considered here. Johnson and Williams [13] additionally applied their model on seven different 
catchment areas. The average values and the range given in Table 7 refer to the values of the 
different areas taken all together. 
Table 7: Comparison of the model performance of the present short-term model (a)) with existing models 
with lower temporal resolution (b) and c)). The percentage of modelled to measured values is calculated and 
averaged in the case of the present short-term model as well as of the model of Johnson and Williams. A mean 
percentage of 100% signifies a perfect agreement of modelled with measured values. The ranges give 
minimum and maximum percentages of the modelled to the measured values. 
a) Present short-term model  Range Mean percentage over the 9 
monthly values 
 Ciprofloxacin 37-520% 137% 
 Norfloxacin 99-390% 212% 
 Trimethoprim 53-96% 76% 
    
b) Heberer and Feldmann [11]  Range Percentage 
 Carbamezine 65-104% 85% 
 Diclofenac 135-157% 146% 
    
c) Johnson and Williams [13]  Range Mean percentage over the 7 
different catchment areas 
 Estrone 60-95% 79% 
 17β-estradiol 56-111% 84% 
 17αethinylestradiol 50-120% 81% 
 
Table 7 shows that the model developed in the present master thesis works overall less precise on 
the long-term than the two models found in literature. For ciprofloxacin and norfloxacin the 
ranges are larger than for the other models. As already hinted before, the hypotheses made on the 
consumed antibiotic amounts might be an important factor contributing to these deviations. 
Beside it, the transit loss fraction could play an important role, too. 
The model results of the two models found in literature show on the other hand average 
deviations of at least 15% to the measurements. Considering the model of the present work as a 
first approach to simulate short-term micropollutants concentration variations the large mean 
percentage deviations seem acceptable. 
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4.2.5 Discussion of deviations and uncertainties 
The comparison of modelled and measured values in section  4.2.3 reveals two types of deviations: 
deviations in the order of magnitude of the resulting values and dynamical deviations. 
These deviations are very likely to arise from the already mentioned random character of the 
model, from uncertainties in the calibrated parameters or an imperfect calibration and the 
hypotheses made in the design of the model. They all act in different ways on the result. 
 
 
The random noise 
Based on the data on medicament prescription from 2006 to 2010 in the Canton of Vaud it is 
estimated that roughly 270 persons consume ciprofloxacin twice a day. For norfloxacin they are 
estimated to be about 100 persons and trimethoprim assumed to be administered 4 times a day by 
about 50 persons every day. These numbers are not big enough to eliminate a certain randomness 
of the cumulated discharge from one day to another. Figure 21 shows by way of example the 
modelled hourly ciprofloxacin from the 31st October to the 4th November 2011. Only workdays are 
considered here because the toilet use distribution of weekend days is likely to differ from the one 
used here in the model [38]. Again, the diurnal pattern of the ciprofloxacin discharge can be 
recognised but the mass entering the sewer at a certain hour is not the same every day. These 
detailed dynamical differences are due to the random character of the model. 
 
Figure 21: Development of the modelled ciprofloxacin mass flow rate entering the 
sewer. During these days there was almost no rain and they correspond to 
workdays only (the underlying toilet use distribution is mainly based on 
workdays). It shows beside the diurnal pattern also differences in the hourly 
dynamics from one day to another that are only due to the random character of the 
antibiotic discharge model. 
 
22 04 10 16 22 04 10 16 22 04 10 16 22 04 10 16 22 04 10 16 22 04
0
1000
2000
3000
4000
5000
6000
7000
Ciprofloxacin
entering sewer system
31.10.2011 − 04.11.2011
Monday − Friday
time [h]
M
FR
 [m
g/h
]
Results 
43 
Figure 22 gives a more precise idea about the extent of this random variability or noise shown on 
the example of December. It is plotted with the parameter set that resulted from the calibration. 
The black line shows the average modelled ciprofloxacin mass discharged into the sewer in 
December. The grey areas around that curve stand for the random noise in terms of the standard 
deviation added to and subtracted from the mean values. The blue bars indicate the absolute value 
of the standard deviation of the corresponding hour showing that during night between 0 and 5 
o’clock the standard deviation is a little bit smaller than for the rest of the day.  
There are fewer persons consuming trimethoprim than ciprofloxacin and norfloxacin. This means 
that the monthly average is more “exposed” to the randomness of the model approach. Therefore 
its standard deviation is relatively higher. On a daily average in this example of December it 
counts to about 28% of the mean mass (black line) while it counts only 22% for norfloxacin and 
10% for ciprofloxacin which is consumed by the highest number of persons. 
 
 
 
 Figure 22a): Mean development of the discharged ciprofloxacin mass flow rate in 
December 2010 (black line) + and – the standard deviation (grey areas). The blue 
bars show the absolute values of the standard deviation. The number of persons 
estimated to consume ciprofloxacin every day is about 270. 
 
  
Figure 22b): Same setting as described in 20a) but this 
time with norfloxacin. The number of persons 
estimated to consume norfloxacin every day is around 
100. 
Figure 22c): Same setting as described in 20a) but this 
time with trimethoprim. The number of persons 
estimated to consume trimethoprim every day is 
around 50. 
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Figure 23 shows again the comparison between measured (pink dashed lines) and modelled (black 
line) values but with introducing this time the standard deviation which is due to the random 
noise. It is shown on the examples of norfloxacin and trimethoprim in summer because these 
substances are stronger influenced by the random model character. By considering these graphs it 
gets clear that the Monte Carlo approach limits the validity of the model results but only on the 
very short-term dynamic. The randomness causes different model results from one run to another 
depending on the parameters randomly chosen in every run. The norfloxacin concentration at 
08:00 for example can be 400 ng/l or 500 ng/l or in-between (see Figure 23). This holds true also 
for 09:00 and 10:00. So, in this time frame the exact concentration dynamic is not clear. The 
principal dynamic throughout the day however is thereby not affected. 
 
Figure 23: Measured and modelled values of 
norfloxacin in summer with addition and deduction 
of the standard deviation resulting exclusively of the 
random character of the model.  
Measured and modelled values of trimethoprim in 
summer with addition and deduction of the standard 
deviation resulting exclusively of the random 
character of the model. 
 
 
The calibrated parameters 
Among the calibrated parameters there are some acting on the order of magnitude of the model 
results and some influencing the dynamic. 
• A given urinary accumulation curve as for example seen in Figure 3 results in a certain 
order of magnitude of the resulting antibiotic concentration in the urine. By the 
calibration a rate is determined which changes the accumulation curve as a whole 
accounting for the given uncertainties in this curve. The detailed dynamic within the 
curve however remains the same. 
 
• The transit loss fraction is a reduction rate accounting for antibiotic losses during the 
transport from the toilet to the STP. It is determined through the calibration and it 
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concerns all hourly values the same. This means that altering the transit loss fraction 
influences only the order of magnitude of the resulting antibiotic concentration. 
Both, the transit loss fraction and the rate of magnitude of the urinary accumulation curve have 
influence only in the order of magnitude of the results. The rates determining the urinary 
accumulation of ciprofloxacin and norfloxacin are both estimated to be slightly higher than 100% 
(109% and 115% respectively). Also their transit loss fractions are estimated to be around 10% 
which tends to compensate the additional urinary accumulation. In the case of trimethoprim both 
calibrated parameters tend to reduce the originally given amount of trimethoprim (81% for 
urinary accumulation and 55% for the transit loss fraction). This could perhaps be due to smaller 
trimethoprim consumption in autumn 2011 compared to the mean amount consumed in autumn 
from 2006 to2010. The calibration is conducted just to account for such uncertainties. The plots of 
the calibration (Figure 13 and Figure 14) indicate that the two parameters are likely to be correctly 
calibrated for all substances. 
However, the validation plot of winter and spring of ciprofloxacin and spring of norfloxacin show 
a deviation in the order of magnitude. If there is not another (not yet considered) reason for these 
deviations perhaps a separate calibration of these two parameters for these seasons would be 
needed. It is conceivable that the transit loss fraction varies from one season to another. Reason 
for this could be for example the diffusion of antibiotics in the biofilms since it is occasionally 
dependent on the temperature [42]. 
 
 
In contrary the other calibrated parameters, namely the mean number of toilet uses a day and its 
standard deviation as well as the standard deviation of the time of the 2nd medicine intake and the 
travel time, they have an impact on the dynamic of the hourly antibiotic occurrence at the STP. 
They are directly coupled to the random choice of certain parameters within the model. That is 
why their influence on the final model results is assessed here in dependence of the variability due 
to the random model approach. 
• An inaccurate determination of the standard deviation of the time of the subsequent 
antibiotic intake(s) has negligible influence in the final result. When changing this 
parameter by adding or subtracting 50% of its number found in the calibration the 
resulting random noise does not noticeably change. 
 
• In the calibration the mean number of toilet uses a day is determined to be twelve or 
eleven depending on the substance. According to the numbers found in literature (see 
Table 4) this corresponds to very high numbers. The best fit of model and measurements 
seems to be achieved with a rather high frequency of toilet uses which implies that the 
amount of antibiotic introduced each time is smaller but on the other hand the antibiotics 
are introduced more continuously than with less toilet uses a day. 
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Varying the mean number of toilet uses in the model shows that the more the mean 
number of toilet uses is reduced, the more the random noise is increased. This is 
reasonable because a smaller number of toilet uses ends up in the more sporadic 
introduction of higher antibiotics amounts which is indicative for a higher variability. 
It seems that with a more realistic mean number of toilet uses as for example 6 times a day 
the random noise gets that high (on average 38% to the mean values in December instead 
of 28% as seen in the previous section) that stronger differences to the measured values 
occur. In the calibration a better fit seems to be fulfilled with a smoother curve which is 
achieved with a smaller random noise by a higher mean number of toilet uses a day. 
 
• The analysis of the standard deviation of the number of toilet uses reveals that an 
overestimation of this parameter leads to a bigger random noise while an underestimation 
reduces the random noise of the final results. The influence of uncertainties in the 
determination of this parameter however is not as big as in the case of the mean number of 
toilet uses a day. This is explained also in the following example: If the validation is run for 
trimethoprim with only 6 instead of 12 toilet uses a day on average (-50%) the resulting 
random noise is about 38% instead of 28% as seen before. If the simulation is run again 
with 12 average toilet uses a day and a standard deviation of the number of toilet uses of 
6.3 instead of 4.2 (+50%) the resulting random noise is about 32% instead of 28%. So the 
increase of the random noise is smaller if the standard deviation of the number of toilet 
uses is changed by 50% of its original value than it is the case with the average number of 
toilet uses. If the same simulation is run with 2.1 as standard deviation of the number of 
toilet uses (-50%) the final random noise is about 23%. So, the random noise gets smaller 
when the standard deviation is smaller. 
The expected standard deviation based on literature (see Table 4) is around 2. For 
ciprofloxacin the calibration determined it to be 2 for norfloxacin it is 3.6 and for 
trimethoprim it is 4.2. Compared to the mean number of toilet uses a day it seems that the 
random noise is increased by the calibration of this parameter but clearly less than it is 
decreased by the calibration of the mean number of toilet uses. 
 
• The travel time is the parameter accounting for the time it takes the antibiotics to be 
transported from toilet to the STP. The calibration determined it to be zero. This is 
reasonable given the short travel time expected in this catchment area and considering also 
the fact that the modelled mass flow rate peak in the morning is already a little late 
compared to the measured one. If this however was wrong the hourly dynamic would be 
kept as it is but the whole concentration curve would be shifted by one hour or by at most 
two hours. Altogether it seems that this parameter is rather not or even not at all 
contributing considerably to the deviations between modelled and measured values. 
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The hypotheses of the model design 
For the design of the model there are also some hypotheses made which could contribute to a 
certain imprecision of the results: 
• On the consumed antibiotic amounts several hypotheses were made: The amount of 
prescribed antibiotics is assumed to equal the amount consumed. This hypothesis includes 
that patients consume always the whole package they bought and that the medicaments 
bought outside but consumed inside the perimeter and the medicaments bought inside and 
consumed outside balance each other. 
Since sold antibiotic amounts are not directly known for the considered area, they had to 
be deduced from data of the pharmacy of the CHUV and from the pharmacy of the whole 
canton of Vaud. 
Additionally for the modelled period from December 2010 to November 2011 the 
antibiotics amount consumed or rather prescribed is assumed to be equal the monthly 
average of prescribed antibiotics from 2006 and 2010. The rate of the standard deviation to 
the mean for these 5 years counts about 7% for ciprofloxacin 16% for norfloxacin and 12% 
for trimethoprim. 
Deviations between the estimated and the real monthly consumption could lead to a 
wrong order of magnitude of the modelled results. As seen in section  4.2.4, the model 
reproduces differences of the amounts of consumed antibiotics quite precisely. This 
however does not impact the daily dynamic. 
There is no way to prevent this problem through the calibration because these data have a 
temporal resolution of one month and the calibration is run for a time period of 24 hours. 
To avoid deviations of this kind the data of the actual considered time period are needed. 
 
• The time of the first antibiotic administration a day is assumed to happen in the same hour 
as the toilet is used the first time. If this does not hold true the urinary accumulation 
would be temporally shifted which finally would impact the short-term dynamic. This 
hypothesis might lose some importance by the fact that the urinary accumulation is 
calibrated in the model although it is only the magnitude of the urinary accumulation 
curve which is calibrated. 
 
• The intravenous administration is not considered in the model. It concerns only 
ciprofloxacin with a contribution of 15 to 20% of the total consumed mass. The 
intravenous application of ciprofloxacin is expected to alter the short-term dynamic of its 
occurrence at the STP inlet since the total mass input to the model remains the same. In 
addition, it would concern all seasons because the frequency of intravenous administration 
is not following a clear seasonality. 
 
• In the model only the urinary excretion is considered. As explained in section  3.2.3, a part 
of the administered antibiotics is excreted by faeces. This is in the majority of the cases a 
minor part but for norfloxacin this does not hold true [4]. Since the excretion via faeces 
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also happens via the toilet it can be regarded as being temporally related with the urinary 
excretion [38]. So this hypothesis concerns mainly the order of magnitude of the 
antibiotics concentration at the STP and does rather not impact its temporal dynamic. The 
urinary accumulation curve is calibrated as a whole which is assumed to have 
compensated also for this aspect. Indeed, the calibration determined the urinary 
accumulation parameter of norfloxacin to be as high as the proposed maximum value of 
115% (see Table 5 and Table 6). 
 
• The toilet use distribution is based on three studies which have investigated in this field 
but primarily in the domain of the domestic toilet use. The toilet use distribution applied 
in this model is finally something like a patchwork of the information given in these 
studies. It is also assumed that the toilet use distribution curves of these studies are all 
related to urinary use. As discussed and shown by Friedler et al. [38]this hypothesis itself is 
not very critical. However, given the strong influence of the toilet use distribution on the 
dynamic of the antibiotic occurrence at the STP inlet the uncertainties existing in this 
model component as a whole might be substantial. 
 
 
4.2.6 Improvements and extensions 
The created model can be regarded as a first attempt to simulate antibiotics concentration in high 
temporal resolution. The results show sometimes considerable deviations compared to the 
measurements in the detailed dynamic as well as in the predicted order of magnitude. The analysis 
of the uncertainties contained in the model showed that a better knowledge about certain aspects 
could lead to a better model performance. 
The model reproduces the entered amount of consumed antibiotic rather precisely. Thus, precise 
consumption data is needed for the time period that is to be modelled.  
A sound knowledge about the local toilet use attitudes would help to reduce uncertainties which 
have a substantial impact on the model results. Using a tracer which is specific for urinary 
excretion such as the ammonium nitrogen loads [39] might be a promising approach to find a 
toilet use distribution which is reliable in particular also for the considered region. 
Furthermore, the good agreement of the modelled and measured values in summer which concern 
a day relatively short before the calibration suggest that one calibration per season instead of one 
per year could improve the model performance. For this, additional short-term measurements 
would be needed. With more measurements also the validation would not be so selective. The 
transit loss fraction is suspected to be seasonal. Even if the calibration would be conducted 
separately for the seasons a more precise determination of the transit loss fraction could promote 
the model performance. For this, better knowledge of the biofilm sorption and biodegradation of 
the antibiotics in the wastewater is needed. 
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The applicability of the model could be extended on other substances. To do so information on the 
accumulation of the substance in the urine and perhaps also in faeces is needed. An important 
precondition is that the substance is mainly excreted via the urine. Another condition would be 
that it is consumed by a large number of persons. Otherwise the random noise will be too large for 
reliable short-term dynamic predictions. To completely eliminate this randomness in the model 
which is presently limiting the validity of the predicted short-term dynamic from one hour to 
another a model approach without the Monte Carlo method would be necessary. 
It could be interesting to extend the model’s applicability on metabolites of the antibiotics. 
Although metabolites of most drugs have a lower ecotoxicological risk they matter and should be 
considered if the model one day should assist to estimate the ecotoxicological risk of 
antibiotics  [4]. 
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5 Conclusions 
 
The behaviour of antibiotics concentration on the long-term have already been investigated and 
modelled multiply and seasonal antibiotics concentration variations have been discovered [7, 15-
17, 41]. Short-term variations are by contrast not very well known yet [9]. They are important in 
the methodical context of antibiotics measurements as well as in concern of the environmental 
impact of antibiotics [1, 6, 9]. For that reason in this project the antibiotics concentration 
variations at the STP inlet at different time scales were analysed and a model is developed 
simulating short-term antibiotics concentration variations at the STP inlet. 
Measurements of six antibiotics (ciprofloxacin, clindamycin, metronidazole, norfloxacin, ofloxacin 
and trimethoprim) were being carried out successfully at the inlet of the STP of Vidy in Lausanne 
for one year. They are arranged in two types of measurement campaigns: one consisting of daily 
measurements for one week every month and the other consisting of hourly measurements for 
one day per season. With the first dataset the expected seasonal variations could be confirmed. 
The measured mass flow rates were in general higher in winter and spring than in summer and 
autumn. The second dataset was used to analyse short-term variations. They revealed a daily cycle 
with a first peak in the morning and a second a little less accentuated increase towards the 
evening. During night the mass flow rates are generally low. This cycle was analytically confirmed 
by the analysis of the periodicity of the measured antibiotics mass flow rate which showed clear 
return periods of 24 and 12 hours for the mass flow rate peaks in the morning and the evening 
respectively.  
The variations of the different time scales (monthly, daily and hourly time scale) were compared 
with each other. The hourly variations within the day were found to reach about the same extent 
as the monthly or seasonal ones. The day-to-day variations however are in general relatively 
small. The seasonal variations are comprehensible in consideration of the seasonality in antibiotics 
consumption [41]. Given the relatively important magnitude of the short-term variations it 
matters to have a good understanding of their origin. 
 
In that context a model was created focusing on the simulation of antibiotics short-term 
concentration variations. It is designed in a first step by the constitution of a model for the 
antibiotic discharge into the sewer on an hourly basis. Parts of the modeol rest upon on a Monte 
Carlo approach and take into account information on the time of the medicament intake, the 
antibiotic accumulation in the urine and the time when the toilet is used. The discharge model is 
coupled with a transport model that simulates the wastewater flow rate in the sewer system. It is 
applied for the catchment area of the STP of Vidy in Lausanne and for three antibiotics 
(ciprofloxacin, norfloxacin and trimethoprim). The calibration was executed with the 24 hourly 
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measurement values of autumn. The comparison of the modelled and measured values was done 
for the 324 hours of the remaining seasons. This is both quite limiting for the validity of this 
direct comparison. However, it is probably the best possible way to calibrate and validate the 
model. 
The predicted concentrations in summer are in good agreement with the measurements. This is 
possibly due to the short time difference (less than two months) to the time frame of the 
calibration. Some of the validation graphs of the remaining seasons show certain deviations in the 
order of magnitude between measured and modelled values. The results of the calibration suggest 
that the deciding parameters acting on the result’s order of magnitude are in principal correctly 
calibrated. It is possible however that the transit loss fraction changes in the course of the year and 
a separate calibration for the different seasons would be necessary to account for that. In addition, 
the model calculations are based on the hypothesis that the monthly average of sold antibiotics 
from 2006 to 2010 corresponds to the consumption of the modelled time period from December 
2010 to November 2011. It is likely that more precise results could be achieved with the exact 
consumption data of the modelled time period. 
The very short-term dynamic from one hour to another shows for all three substances some 
discrepancies. This holds true for the calibration results, too. The detailed hourly antibiotics 
dynamic cannot perfectly be predicted because of the noise caused by the randomness of the 
Monte Carlo approach. The random noise is the more reduced the more random samples are 
taken. So, ciprofloxacin showed the smallest random noise because it is consumed by a higher 
number of persons than the other two antibiotics. Important peaks or dynamics throughout the 
day are however not affected by the random noise. 
The modelled short-term dynamic of the antibiotics is additionally influenced by uncertainties in 
the determination of the hours when the toilet is used. The moment the toilet is used there will be 
antibiotics entering the sewer which demonstrates the relevance of this aspect. The toilet use 
distribution and the mean number of toilet uses a day can be assumed to be the most powerful 
factors concerning their influence on the short-term antibiotics dynamics. The calibration 
revealed rather high values for the mean number of toilet uses a day (around 12) which indicates 
certain uncertainties in this aspect. The toilet use distribution curve is based on literature values 
on domestic toilet use and contains some hypotheses incorporated during its assemblage. 
By comparing in a more general sense the diurnal dynamics of the modelled and the measured 
mass flow rates side by side a certain resemblance appears. In both cases a strong peak in the 
morning between 07:00 and 10:00 was found and a second one towards the evening between 17:00 
and 21:00. The latter is a little less accentuated in both cases. 
The comparison of the modelled values with the measured concentration on the long-term over 
months revealed that the modelled values agree not too bad with the measurements. Again, the 
hypotheses on the antibiotics consumption and the lack of knowledge about losses during the 
transit from toilet to the STP could be cited here for the observed deviations. 
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The created model is a first attempt to simulate antibiotics concentration on an hourly basis. There 
are still a lot of improvements that could be done and possibilities to extend the model like for 
example the application on other substances. Despite the discussed deviations between the model 
results and the measurements the development of the model allowed identifying the most 
important parameters contributing to the short-term dynamic: Firstly, the amount of consumed 
antibiotic and the number of persons administering the medicine are very important model inputs. 
Secondly, it is essential to have good information about the pharmacokinetics of the considered 
substances. This means more precisely that the amount and dynamic of the accumulation of the 
antibiotics in the urine and faeces in unchanged as well as in metabolised form are basic 
requirements for reliable model calculations. And thirdly, the time when the toilet is used is very 
deciding because it is the moment when the antibiotics are released into the sewer. 
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Appendix 
Flow rates 
Table 8 : Flow rates during monthly campaigns at the STP inlet in m3/s 
Date MON TUE WED THU FRI  SAT SUN MON TUE WED THU 
2011 14.-21. March 1.111 0.916 0.997 0.997 0.997 0.997 1.005 
    
 08.-15. April 
    
1.111 0.916 0.950 0.997 1.005 0.971 0.988 
 06.-13. May 
    
0.908 0.857 0.854 0.957 0.939 0.924 1.080 
 17.-24. June  
    
1.398 1.407 0.878 0.880 0.890 1.367 1.027 
 08.-15. July 
    
0.838 0.956 1.126 1.137 1.189 1.519 0.850 
 19.-26. August 
    
1.062 0.938 0.958 0.987 1.004 0.856 0.869 
 09.-16 September 
    
1.062 0.938 0.958 0.987 1.004 0.856 0.869 
 07.-14. October 
    
0.866 1.119 1.052 1.028 0.817 0.831 0.847 
 11.-18. November 
    
0.834 0.876 0.779 0.861 0.813 0.851 1.072 
 06.-13. December 
 
1.014 1.679 1.173 0.958 0.754 0.786 1.404 
   
2012 06.-13. January 
    
1.666 1.544 1.511 1.326 1.233 1.162 1.119 
 03.-10. February 
    
0.981 0.901 0.846 0.970 0.966 0.986 0.834 
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Table 9: Flow rates during seasonal campaigns at the STP inlet in m3/s 
 Winter Spring Summer  Autumn 
 06.-07.12.2010 17.-18.05.2011 06.-07.09.2011 02.-03.11.2011 
 MON-TUE TUE-WED TUE-WED WED-THU 
6.00    - 
7.00 6.019 1.080 1.043 0.565 
8.00 8.271 1.354 1.247 1.157 
9.00 8.988 1.201 1.403 1.391 
10.00 8.988 1.136 1.048 1.258 
11.00 8.988 1.223 0.932 1.112 
12.00 8.988 1.142 1.038 1.001 
13.00 8.988 1.085 1.214 0.853 
14.00 11.156 0.980 1.127 1.060 
15.00 12.484 0.890 0.891 0.375 
16.00 12.832 0.912 0.855 1.028 
17.00 12.832 0.771 0.869 0.885 
18.00 12.660 0.915 0.815 1.098 
19.00 14.866 1.068 0.972 0.981 
20.00 16.033 1.244 1.054 1.137 
21.00 16.454 1.186 1.002 1.189 
22.00 16.095 0.914 1.035 1.070 
23.00 14.621 0.830 0.817 1.042 
24.00 13.897 0.667 0.697 0.808 
1.00 14.146 0.559 0.600 0.602 
2.00 13.828 0.491 0.579 0.864 
3.00 13.065 0.475 0.560 1.109 
4.00 13.065 0.469 0.612 0.513 
5.00 13.065 0.472 2.211 0.456 
6.00 13.065 0.586 0.855  
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Antibiotics 
Ciprofloxacin 
Table 10 : Measured ciprofloxacin concentrations of monthly campaigns at the STP inlet in ng/l 
Date MON TUE WED THU FRI  SAT SUN MON TUE WED THU 
2011 14.-21. March 2729.95 3072.7 3069.8 1752.7 2413.05 1990.8 2436.4 
    
 08.-15. April 
    
1828.1 1805.7 1516.3 1921.6 1818.7 1781.7 1788.1 
 06.-13. May 
    
1995.1 1997.3 2172.3 2454.8 3142.9 2339 2386.8 
 17.-24. June  
    
634.8 448.6 1052.8 1662.9 1317.3 692.8 679.6 
 08.-15. July 
    
908.4 843.9 616.9 854.6 628.7 406.5 818.7 
 19.-26. August 
    
738.5 645.15 625.95 642.5 639.4 718.5 678.7 
 09.-16 September 
    
643.7 759.05 645.05 848.8 692.95 678.95 741.2 
 07.-14. October 
    
158.1 97.65 249.3 226.9 202.65 185.45 284.7 
 11.-18. November 
    
632 845.8 1207.1 1411.6 1077.5 471.7 1794.7 
 06.-13. December 
 
1224.4 878.9 1507.5 1854.75 1895.15 2517 968.45    
2012 06.-13. January 
    
602.45 794.3 894.3 1239.4 1110.45 1146.75 1190.45 
 03.-10. February 
    
1702.05 1745.45 1878.05 1942.6 1801.25 1693.6 1993.8 
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Table 11: Measured ciprofloxacin concentrations of seasonal campaigns at the STP inlet in ng/l 
 Winter Spring Summer  Autumn 
 06.-07.12.2010 17.-18.05.2011 06.-07.09.2011 02.-03.11.2011 
 MON-TUE TUE-WED TUE-WED WED-THU 
6.00    1529.4 
7.00 397.6 2584.7 1166.1 1609.8 
8.00 1922.4 2792.7 1130.7 1949.5 
9.00 4186.1 3475.2 1550.3 1875.4 
10.00 1147.7 4013.2 1093.2 1474.8 
11.00 2455.8 3387.5 1685.1 1496.2 
12.00 738.3 3966.0 951.9 976.2 
13.00 621.5 3187.4 992.4 1235.3 
14.00 201.1 2806.4 956.4 1063.8 
15.00 790.5 3104.4 1250.6 788.3 
16.00 989.7 2531.2 545.9 1475 
17.00 700.9 3343.7 809 805.1 
18.00 1927.2 2052.6 853.7 557.4 
19.00 2963.1 1986.8 1118.5 979.9 
20.00 1110.4 2510.0 792.5 1174.7 
21.00 1443.2 1875.9 944.6 1181.2 
22.00 305.4 2340.2 573.5 1030.8 
23.00 766.5 2243.6 527.4 922 
24.00 557.9 1863.2 825.2 885.1 
1.00 143.2 1365.2 733.7 1046.9 
2.00 510.7  743.2 881 
3.00 150.1  563.6 560.8 
4.00 237.5  597.3 495.1 
5.00 548.4  507.6 810.2 
6.00 392.7 1845.6 910.4  
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Clindamycin 
Table 12 : Measured clindamycin concentrations of monthly campaigns at the STP inlet in ng/l. Numbers in red are between the limit of detection (LOD) and the limit of 
quantification (LOQ) 
Date MON TUE WED THU FRI  SAT SUN MON TUE WED THU 
2011 14.-21. March 12 10.75 11.1 9.7 13.95 10 11.4     
 08.-15. April 
    
4.1 5.3 4.9 4.6 4.7 7.1 6.1 
 06.-13. May 
    
9.9 7 7.1 7.4 8.7 7.7 6.7 
 17.-24. June  
    
4.9 2.4 9.8 8.2 9.6 5.9 5.8 
 08.-15. July 
    
7.4 7.6 5.1 5 6.5 5.7 6.2 
 19.-26. August 
    
3.7 2.1 < LOQ 1.6 3.4 3.25 2.45 
 09.-16 September 
    
6.35 7.2 6.4 6.25 6.8 5.25 5.6 
 07.-14. October 
    
       
 11.-18. November 
    
7.9 5.5 8.8 8.7 7.7 4.6 2.1 
 06.-13. December 
 
8.2 4.85 8.5 6.1 8.3 6.6 4.55    
2012 06.-13. January 
    
8.05 5.95 7.4 9.8 10.7 6.7 6.7 
 03.-10. February 
    
2.85 1.55 1.3 1.05 < LOD < LOD 1.6 
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Table 13: Measured clindamycin concentrations of seasonal campaigns at the STP inlet in ng/l 
 Winter Spring Summer  Autumn 
 06.-07.12.2010 17.-18.05.2011 06.-07.09.2011 02.-03.11.2011 
 MON-TUE TUE-WED TUE-WED WED-THU 
6.00    9 
7.00 1.1 19.5 15 10.5 
8.00 5.9 9.0 16.8 14.2 
9.00 5.1 21.3 14.4 11.1 
10.00 4.8 8.8 8.5 10.1 
11.00 2.7 5.3 5.9 5.9 
12.00 3.6 4.4 5.1 5.8 
13.00 3 5.7 6.4 4.8 
14.00 2.4 5.8 5 4.3 
15.00 3.2 4.0 7.9 4 
16.00 2.5 8.3 5.6 4.9 
17.00 5.5 4.8 5.2 7.9 
18.00 1.9 7.0 2 3.9 
19.00 2.1 2.8 7 4 
20.00 2.7 2.7 7 1.6 
21.00 1.1 2.8 6.7 3 
22.00 1.8 2.3 8.1 3.4 
23.00 <LOD 5.6 7.3 7.6 
24.00 1.1 4.0 5.8 4.5 
1.00 1.3 3.3 5 3.4 
2.00 1.4  8.8 5.4 
3.00 1  6.8 2.3 
4.00 <LOD  2.4 1.8 
5.00 1  5.4 11.2 
6.00 1.1 23.5 11  
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Metronidazole 
Table 14 : Measured metronidazole concentrations of monthly campaigns at the STP inlet in ng/l 
Date MON TUE WED THU FRI  SAT SUN MON TUE WED THU 
2011 14.-21. March 402.4 130.5 245.75 399.2 122.3 86.05 53.55 
    
 08.-15. April 
    
476.2 100.7 49.7 620 113.7 114.2 127.1 
 06.-13. May 
    
1441.7 206 72.9 777.6 123.9 983.8 246.3 
 17.-24. June  
    
343.9 587.4 58.5 599.6 367.1 305.9 495.4 
 08.-15. July 
    
509.9 103.4 92 380.5 159.5 315 279 
 19.-26. August 
    
3534.95 537.95 229.35 1396.1 1143.6 1657.35 1970 
 09.-16 September 
    
6725.35 804.95 171.2 2418.95 1616.45 490.35 661.45 
 07.-14. October 
    
       
 11.-18. November 
    
2258.9 2011.9 230 487.5 526.5 407.9 1045.9 
 06.-13. December 
 
4159.2 5637 1344.85 5662.95 2753.2 882.75 1432.1    
2012 06.-13. January 
    
9690.3 6332.8 838.95 2304.5 3663.8 12077.8 5198.25 
 03.-10. February 
    
46317.1 11531.15 2488 11068.7 5898.15 11539.15 28265.65 
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Table 15: Measured metronidazole concentrations of seasonal campaigns at the STP inlet in ng/l 
 Winter Spring Summer  Autumn 
 06.-07.12.2010 17.-18.05.2011 06.-07.09.2011 02.-03.11.2011 
 MON-TUE TUE-WED TUE-WED WED-THU 
6.00    316.2 
7.00 <LOD  104 208.2 
8.00 <LOQ  441.1 1376.6 
9.00 9.7  728.9 1162.6 
10.00 42  1038.5 296.6 
11.00 3.6  956.4 166.5 
12.00 6.9  594.1 168.9 
13.00 5.9  534.9 280.3 
14.00 6.5  624.9 819.7 
15.00 10.3  540.9 2342.8 
16.00 4.6  1169.5 929.8 
17.00 17  3809.8 518.1 
18.00 12.3  3117.3 197.9 
19.00 4.3  450 95.4 
20.00 <LOD  107.6 144 
21.00 <LOQ  108.9 181.4 
22.00 <LOD  204.4 119.9 
23.00 4.7  158.4 185.8 
24.00 <LOQ  200.9 116.8 
1.00 <LOQ  229.3 104.2 
2.00 <LOD  136.8 128.7 
3.00 <LOQ  233.8 157.5 
4.00 <LOQ  217.6 135.7 
5.00 14.7  227.1 486.1 
6.00 3.0  175  
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Norfloxacin 
Table 16 : Measured norfloxacin concentrations of monthly campaigns at the STP inlet in ng/l 
Date MON TUE WED THU FRI  SAT SUN MON TUE WED THU 
2011 14.-21. March 197.8 169.4 207.85 162.75 206.85 181.5 200.05 
    
 08.-15. April 
    
161.9 156.3 141.7 160.3 139.1 198.2 161.1 
 06.-13. May 
    
81.6 75.5 100.5 90.5 102.7 92.5 83.7 
 17.-24. June  
    
80.6 36.3 104.2 107.7 106.2 67.1 80 
 08.-15. July 
    
82.1 111 68.2 66.5 85 33.5 45.3 
 19.-26. August 
    
325.4 468.8 473.3 447.65 466.5 428.95 458.4 
 09.-16 September 
    
202.65 376.75 288.9 274.65 225.7 259.85 334.85 
 07.-14. October 
    
145.6 87.6 181.4 160.5 117.7 125.55 161.8 
 11.-18. November 
    
313.1 350.8 487.2 434.3 462.8 272.6 154.7 
 06.-13. December 
 
960.4 625.55 892.9 1241.6 1214.5 1283.8 572.7    
2012 06.-13. January 
    
381.4 377.45 439 673.45 598.6 673.45 675.75 
 03.-10. February 
    
2337.05 2400.65 1649.15 1980.1 2278.4 1811.45 1977.9 
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Table 17: Measured norfloxacin concentrations of seasonal campaigns at the STP inlet in ng/l 
 Winter Spring Summer  Autumn 
 06.-07.12.2010 17.-18.05.2011 06.-07.09.2011 02.-03.11.2011 
 MON-TUE TUE-WED TUE-WED WED-THU 
6.00    582.5 
7.00 9.9 72.2 149.7 568 
8.00 11.9 74.3 463.2 727 
9.00 25.5 70.6 452.7 555.9 
10.00 30.2 83.8 534.3 464.9 
11.00 23.7 96.2 329.4 530.3 
12.00 18.4 90.8 401.9 485.1 
13.00 18.7 54.2 417.9 399.1 
14.00 13.1 67.9 456.7 427.8 
15.00 27.9 66.5 360.8 257.2 
16.00 21.8 42.5 327.8 426 
17.00 11 42.0 544.7 259.6 
18.00 35 52.6 312.7 244.9 
19.00 24.1 40.4 322.4 356.1 
20.00 11 45.4 314.7 442.4 
21.00 9.9 39.7 301.4 450.2 
22.00 14.7 32.5 289.2 390.6 
23.00 <LOQ 38.3 266.9 343.3 
24.00 10.4 43.3 241.6 376.6 
1.00 7.1 60.5 257 379 
2.00 7.9  209.7 280.3 
3.00 7.9  219 190.4 
4.00 4.3  173.1 245.8 
5.00 6.5  192.6 266.5 
6.00 7.5 88.4 256.1  
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Ofloxacin 
Table 18 : Measured ofloxacin concentrations of monthly campaigns at the STP inlet in ng/l 
Date MON TUE WED THU FRI  SAT SUN MON TUE WED THU 
2011 14.-21. March 740.55 648 760.1 454.95 700.95 515.25 716.45 
    
 08.-15. April 
    
531.9 578.1 536.4 576 452.3 506.2 405.7 
 06.-13. May 
    
444.2 397 373.4 367.1 500.3 495.5 347 
 17.-24. June  
    
90.7 53.3 99 101.2 135.1 60.1 82.5 
 08.-15. July 
    
120.5 120.2 115.3 173.4 106.5 62.6 111.9 
 19.-26. August 
    
292.8 205.05 185.65 224.2 205.75 176.65 207.95 
 09.-16 September 
    
374.8 412.05 349.55 324.5 249.1 276.8 456.6 
 07.-14. October 
    
26.55 22.65 43.8 30.55 20.05 18.4 33.2 
 11.-18. November 
    
408.7 537.8 878 617.6 521.2 248.5 936.6 
 06.-13. December 
 
796.1 373.95 672.45 837.35 945.2 984.8 591.85    
2012 06.-13. January 
    
290.4 258.8 300.05 362.75 474.95 462.9 429.6 
 03.-10. February 
    
232.8 257.85 234.85 219.65 225.65 203.65 222.1 
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Table 19: Measured ofloxacin concentrations of seasonal campaigns at the STP inlet in ng/l 
 Winter Spring Summer  Autumn 
 06.-07.12.2010 17.-18.05.2011 06.-07.09.2011 02.-03.11.2011 
 MON-TUE TUE-WED TUE-WED WED-THU 
6.00    930.9 
7.00 13.3 742.3 250.2 1166.7 
8.00 74.6 937.5 418.2 858.1 
9.00 195.4 684.6 426.4 770.4 
10.00 422.9 441.6 310.1 528.3 
11.00 1865.3 188.8 351 460.1 
12.00 108.8 283.4 248.7 377 
13.00 11.4 610.2 282 293.1 
14.00 <LOQ 363.1 319.2 257.5 
15.00 29.4 455.4 241.7 270 
16.00 17.1 1198.8 118.2 690.5 
17.00 65.6 406.9 356.3 327.8 
18.00 101 695.9 189.5 122.1 
19.00 53.8 188.0 288.6 306.8 
20.00 35.4 264.2 266.7 459.4 
21.00 61.5 329.6 300.8 470 
22.00 44.6 383.3 163.8 344.1 
23.00 11 265.0 179.6 212.7 
24.00 <LOQ 375.3 198.5 318.4 
1.00 <LOQ 205.9 233.7 222.8 
2.00 10.9  182.5 148 
3.00 <LOQ  141.7 148.7 
4.00 11.2  140.5 186.2 
5.00 15.2  117.5 496 
6.00 20 437.5 182.8  
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Trimethoprim 
Table 20 : Measured trimethoprim concentrations of monthly campaigns at the STP inlet in ng/l 
Date MON TUE WED THU FRI  SAT SUN MON TUE WED THU 
2011 14.-21. March 70.55 80.65 84.35 55.5 73.4 80.8 75.35 
    
 08.-15. April 
    
55 58.3 56.1 58.6 49.2 56.3 60.2 
 06.-13. May 
    
79.1 76.3 84.6 74.6 59.9 70.6 61.5 
 17.-24. June  
    
61.2 36.8 81.9 70.4 75.2 50 69 
 08.-15. July 
    
67.6 76.8 64 59.9 62.1 50.7 73.8 
 19.-26. August 
    
73 92.85 87.05 80.05 83.6 93.9 97.9 
 09.-16 September 
    
63.8 96.15 89.65 82.1 87.05 72.7 80.55 
 07.-14. October 
    
       
 11.-18. November 
    
60.5 60.8 86.5 82.3 68 39.8 27 
 06.-13. December 
 
119 97.65 118.3 127 142.25 139.6 90.65    
2012 06.-13. January 
    
86.7 103.25 120.65 133.8 113.9 134 115.15 
 03.-10. February 
    
62.65 66.9 61.65 49.2 66.7 75.45 70.5 
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Table 21: Measured trimethoprim concentrations of seasonal campaigns at the STP inlet in ng/l 
 Winter Spring Summer  Autumn 
 06.-07.12.2010 17.-18.05.2011 06.-07.09.2011 02.-03.11.2011 
 MON-TUE TUE-WED TUE-WED WED-THU 
6.00    124 
7.00 15.9 118.6 169 93.2 
8.00 32.1 76.5 90.6 82.9 
9.00 70.1 50.0 80.1 71.4 
10.00 42.3 52.0 58.9 69.1 
11.00 26 37.3 57.4 61 
12.00 41.1 44.0 42.6 43.8 
13.00 11.4 36.5 50 51.8 
14.00 22.8 42.5 61.7 43.5 
15.00 7.7 40.5 58 44.2 
16.00 30.9 40.7 47.6 48.7 
17.00 17.5 40.9 43 57.1 
18.00 16.1 81.6 52 35 
19.00 11.5 22.0 57.5 47.2 
20.00 16.6 35.4 46.6 52.1 
21.00 14.2 33.3 52.5 52 
22.00 11 42.1 60 58.1 
23.00 12.8 28.1 56.1 73.3 
24.00 11.4 26.2 52.8 40.6 
1.00 6.8 43.8 78.3 27.5 
2.00 10  92 46.6 
3.00 7.6  73.2 55.9 
4.00 7.4  72.2 54.6 
5.00 10.1  76.9 102.7 
6.00 20.4 59.6 81.9  
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Urinary Accumulation 
 
Figure 24: Accumulation of the three modelled antibiotics in the urine after single oral doses, 500 mg for 
ciprofloxacin, 400 mg for norfloxacin and 160 mg for trimethoprim. The accumulation curves are based on 
[33], [30] and [43] respectively 
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Modelled flow rates  
 
 
Figure 25a): Flow rate in spring (blue) resulting from the transport model with the precipitation (in black) as 
a predominant factor in the model 
 
Figure 25b): Flow rate in summer (blue) resulting from the transport model with the precipitation (in black) 
as a predominant factor in the model 
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Figure 25c): Flow rate in autumn (in blue, below) resulting from the transport model with the precipitation 
(in black, above) as a predominant factor in the model 
 
 
